Subscribe to RSS
DOI: 10.1055/s-2004-835835
Diet-Derived Phenols in Plasma and Tissues and their Implications for Health
M. N. Clifford
Centre for Nutrition & Food Safety
School of Biomedical & Molecular Sciences
University of Surrey
Guildford
Surrey GU2 7XH
UK
Fax: +44-1483-300374
Email: M.Clifford@Surrey.ac.uk
Publication History
Received: March 5, 2004
Accepted: June 4, 2004
Publication Date:
10 January 2005 (online)
- Abstract
- Introduction
- The Diversity of Dietary Phenols, Polyphenols and Tannins
- The Consumption of PPT
- Absorption and Metabolism of PPT
- Plasma Pseudo-Pharmacokinetics
- Protective Mechanisms other than Radical Scavenging
- Conclusions
- References
Abstract
This paper seeks to catalyse a reappraisal of the nature, fate and biological significance in humans of phenols, polyphenols and tannins (PPT) consumed in normal diets, and in particular questions the primacy of PPT radical-scavenging mechanisms for the supposed health benefits of diets rich in fruits and vegetables. PPT are classified by structure and function. Arguments are presented to show that cinnamates and derived polyphenols make significantly larger contributions to the total PPT intake than the flavonols and flavones upon which the vast majority of attention has been focussed previously. Daily intakes of total PPT may range from less than 100 mg to in excess of 2 g, and the critical importance of coffee and black tea as the major dietary sources is shown. Only some 5 % of the dietary PPT is absorbed in the duodenum, and of this only some 5 %, mainly flavanols, reaches the plasma unchanged, the balance being mammalian conjugates. Over 95 % of the intake passes to the colon and is fermented by the gut microflora. A fraction of the resulting microbial metabolites is absorbed and appears in the plasma primarily as mammalian conjugates. Even following high intakes of PPT, the plasma metabolites collectively make a very small (less than 5 %) and transient contribution to the total concentration of redox active substances in plasma. This explains the failure of most studies that sought to detect an increase in plasma antioxidant power after consuming a PPT-rich meal or supplement. The powerfully antioxidant PPT aglycones, much used in in vitro studies, do not reach the plasma. The redox potential of those unchanged PPT and PPT metabolites that reach the plasma enables them to scavenge damaging radicals, but the endogenous plasma antioxidants, especially ascorbate, are required for disposal of the resultant phenoxyl radicals. Black tea and coffee, the major sources of PPT, are poor sources of ascorbate. It is suggested that if diets rich in fruits and vegetables are health-promoting, and if these effects are due to PPT, then alternatives to radical-scavenging mechanisms must be sought. Evidence is presented to show that some mammalian metabolites of PPT may indeed be able to protect the vascular endothelium and that diets rich in PPT may in humans at normal dietary levels have the ability to protect against Type II diabetes and the metabolic syndrome through effects on glucose absorption and associated hormones. Such effects are recommended for further investigation.
Key words
Absorption - antioxidants - black tea - chlorogenic acids - cinnamates - coffee - derived polyphenols - diabetes - flavonoids - fruit - GIP - GLP1 - gut microflora - hydroxycinnamates - insulin - metabolism - phenols - polyphenols - tannins - review - vegetables
Introduction
Simple phenols, polyphenols and tannins (PPT) have been of great interest for many years, in part because of their impact on the colour, odour and flavour of foods and beverages [1], but more recently because of the possibility that these substances may have health-protecting properties [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]. PPT may be classified in several ways, for example, by biosynthetic origin, occurrence, function or effect, or structure [1], [12], [14]. A classification based on structure and function will be used in this paper [15]. Simple phenols are substances containing only one aromatic ring and bearing at least one phenolic hydroxy group and possibly other substituents, whereas polyphenols contain more than one such aromatic ring. Phenols and polyphenols may occur as unconjugated aglycones or as conjugates, frequently with sugars, organic acids, amino acids, lipids, etc. [16].
#The Diversity of Dietary Phenols, Polyphenols and Tannins
The commonest simple phenols are cinnamates that have a C6-C3 structure [17], [18] accompanied by C6-C2 and C6-C1 compounds, and a few unsubstituted phenols [19], [20], [21]. In general these occur as conjugates. Flavonoids are the most extensively studied polyphenols, all characterised by a C6-C3-C6 structure, subdivided by the nature of the C3 element into anthocyanins, chalcones, dihydrochalcones, flavanols, flavanones, flavones, flavonols, isoflavones and proanthocyanidins. The flavanols and proanthocyanidins generally occur unconjugated but the others normally occur as glycosides. Since the seminal paper of Hertog et al. [22] there has been a tendency to think of dietary PPT as encompassing only the flavonoids, and the flavonoids per se to consist only of the three flavonols and two flavones that featured in that study, but this is misleading and was never intended. It is not possible to say with precision just how many individual PPT occur regularly in human diets, but on present evidence a figure in excess of 200 seems reasonable [16].
The term ”tannin” refers historically to crude plant preparations that are capable of converting hides to leather [23] and such preparations are not consumed as human food. However, the functional polyphenols contained therein at high concentrations may also occur in certain foods and beverages but at comparatively low concentrations that would render them totally ineffective for producing leather. These polyphenols may be subdivided into the flavonoid-derived proanthocyanidins (condensed tannins) [24] and the gallic acid-derived and ellagic acid-derived hydrolysable tannins, this latter subgroup being of more restricted occurrence in human food (but commoner in some animal feeds) [25]. The phloroglucinol-derived phlorotannins, while never used for preparing leather, also have a limited occurrence in human food [19]. The more recent term ”phytoestrogen” refers to substances with oestrogenic and/or anti-androgenic activity at least in vitro, and encompasses some isoflavones, some stilbenes, some lignans and some coumarins [26]. The lignans are not oestrogen-active until transformed by the gut microflora [26], [27]. ”Antioxidants” is a third function-based term much used to describe PPT, but individual compounds differ markedly in their ability to scavenge reactive oxygen species and reactive nitrogen species, and inhibit oxidative enzymes. Mammalian metabolites of PPT do not necessarily retain fully the antioxidant ability of the PPT found in plants and especially not that of their aglycones as commonly tested in vitro [28], [29].
The PPT discussed above are substances found in healthy and intact plant tissues, and in the main are of known structure. However, many traditional foods and beverages as consumed have been produced by more or less extensive processing of such plant tissues, resulting in biochemical or chemical transformations of the naturally-occurring PPT. In some cases, black tea, matured red wines, and coffee beverage, for example, these transformations may be substantial, generating large quantities of substances not found in the original plant material. Despite significant advances in the last decade [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], the structures of the majority of these novel compounds have yet to be elucidated. Although often described as tannins, these substances are not functional tanning agents, and should be referred to collectively as derived polyphenols until such time as their full structural characterisation permits a more precise nomenclature.
#The Consumption of PPT
There have been several attempts to estimate the quantities of PPT consumed, either by using diet diaries or food frequency questionnaires and data on the typical composition of individual commodities [3], [8], [42], [43], [44], [45], [46], [47], [48], [49], [50], or by diet analysis [6], 22], [51]. In comparison with the comprehensive databases providing the content in the diet of the established micro- and macro-nutrients, data for the contents of PPT are much more limited. Those data available for PPT content have been obtained by many different methods of analysis, rarely take account of the effects of agricultural practice, season, cooking or commercial processing, are not necessarily just for the edible portion, and may be for varieties of fruit and vegetable different from those consumed in a particular diet under investigation [45], [46], [52].
These are potentially serious limitations since quantitatively cultivars may differ substantially in composition, and the non-edible parts of fruits and vegetables may differ greatly both quantitatively and qualitatively, compared with the flesh or juice [53]. In addition, domestic cooking and commercial processing may in some cases cause extensive leaching and destruction [54], [55], [56], [57], [58], [59], [60].
Data based upon analysis of particular diets avoid these limitations but are usually restricted to a few PPT because of the difficulties and cost associated with quantifying so many individual compounds of known structure, to say nothing of the serious difficulties associated with quantifying the uncharacterised derived polyphenols [61]. When such data are available, they are usually for PPT as aglycones released by hydrolysis (to simplify the analysis still further) and generally for the flavonols and flavones first studied by Hertog et al. [22] since these are amongst the easiest to determine [44], [47], [48], [51], [52], [62], [63], [64], [65], [66], [67], [68]. There are more limited data for flavanones [44], [64] and isoflavones after hydrolysis [44], [52], and flavanols, and proanthocyanidins [6], [69] (which occur as aglycones).
In an attempt at modest cost to shed more light on the nature and quantity of PPT consumed by various populations we developed a computerised spreadsheet database beginning with the several hundred papers identified in the NEODIET reviews [16] with continued updating as more information has been published or found [17], [52], [70], [71], [72], [73], [74], [75]. The database covers 80 commodities, including five alcoholic beverages, six fruit juices and three other non-alcoholic beverages, and 14 PPT subgroups including derived polyphenols, with every entry labelled to show the paper(s) from which the information was taken. Data sources have been restricted to papers using specific methods of analysis: data for ”total phenols by Folin-Ciocalteu” or ”total antioxidant power as gallic acid equivalents” and similar, have been excluded. In order to reflect the variability in composition, data have always been entered as ”high” and ”low” values (mean ± 2σ wherever possible) and an overall mean for each commodity used in determining the amounts of PPT consumed.
While recognising the limitations (discussed above) of such an approach to estimating diet composition and the intake of PPT, using this database in conjunction with diet diaries available from our other studies [76], [77], [78] has produced interesting data (Table [1]) and insights.
From Table [1] it is clear that PPT intakes may vary substantially, and that the flavones and flavonols, upon which most emphasis has so far been placed [22], [44], [47], [48], [51], [52], [62], [63], [64], [65], [66], [67], [68], form a comparatively small part of the total intake for the populations studied. The relatively low consumption of chalcones and dihydrochalcones, isoflavones, anthocyanins, and stilbenes reflects the comparatively low consumption of apples and ciders, soya products, dark berries and red wines by these populations. The significant contributions made by the hydroxycinnamates (in these populations primarily reflecting coffee consumption [17], [18]) and derived polyphenols (in these populations primarily reflecting black tea consumption [79], [80], [81]) are striking. In this context ”black tea” refers to the beverage prepared from the fermented leaf (as distinct from green tea) and not to the addition or otherwise of milk to the beverage prior to consumption. This domination by PPT from black tea and coffee indicates the importance also of considering the hydroxycinnamates and derived polyphenols whenever assessing the dietary significance of PPT, and clearly shows the limitations of looking only at flavonols and flavones after hydrolysis no matter how precise per se the data for these aglycones might be.
It is important to stress that data for the composition of black tea and coffee beverage reflect exactly what is consumed (with the exception of the dregs left in the cup) since all transformations associated with processing and domestic preparation have already taken place. Moreover, the NEODIET database is replete with analytical data from numerous sources for the composition of these beverages (thus better avoiding extreme values associated with any peculiarity of the material analysed or method of analysis) compared with data for many fruits and vegetables. Accordingly, the estimated consumption figures obtained using this database are likely to be more accurate than would have been the case if solid foods were the major sources of PPT, and data were for raw rather than after cooking/processing. This argument applies also to the data for PPT delivered by wines and juices. Using this approach has led us to estimate typical mean intakes of PPT for the two populations so far studied to be in the range 450 to 600 mg as aglycones.
PPT | 103 UK females aged 20 - 30 yearsa | 50 UK males aged 27 - 57 yearsb | ||
Estimated as conjugates | Estimated as aglyconesc | Estimated as conjugates | Estimated as aglyconesc | |
Total, range | 100 - 2 300 | 30 - 2 200 | ||
Total, mean | 780 | 451 | 1058 | 598 |
Hydroxybenzoates | 15 | 23 | ||
Hydroxycinnamates | 353 | 176 | 670 | 335 |
Total flavonoids | 210 | 105 | 205 | 103 |
Anthocyanins | 5 | 9 | ||
Chalcones and dihydrochalcones | 0.7 | |||
Flavanols | 64 | 58 | ||
Flavanones | 22 | 89 | ||
Flavones | 72 | 17 | ||
Flavonols | 35 | 26 | ||
Isoflavones | 9 | 0.13 | ||
Proanthocyanidins | 7 | 6 | ||
Ellagitannins | 23 | |||
Derived polyphenols | 170 | 170 | 160 | 160 |
Stilbenes | 9 | |||
Lignans | 0.04 | |||
a Ref. [49]. | ||||
b Ref. [50]. | ||||
c Aglycones are estimated approximately by taking rutin as a representative flavonoid and 5-caffeoylquinic acid as a representative hydroxycinnamate and adjusting for the relevant molecular masses. |
Absorption and Metabolism of PPT
Extensive studies in humans and animals have indicated that some PPT can be absorbed in the small intestine, for example, certain cinnamate conjugates [82], [83], flavanols [84] (that occur naturally as aglycones), and certain flavonoid glucosides [85], [86] (but not the corresponding flavonoid rutinosides [87]). The mechanisms of absorption have not been completely elucidated but involve inter alia interaction of certain glucosides with the active sugar transporter (SGlT1) and lumenal lactase-phloridzin hydrolase, passive diffusion of the more hydrophobic aglycones, and interaction with cytosolic β-glucosidase. Although varying with PPT subclass and matrix, when expressed relative to the total intake of PPT, only some 5 to 10 % of the amount consumed is absorbed at this site. The major part of that absorbed (90 to 95 % for every substance so far studied) enters the circulation as mammalian conjugates produced by a combination of methylation, sulphate conjugation, glucuronide conjugation and, in the case of some phenolic acids, also by glycine conjugation [29]. Only a very small amount of the total PPT consumed, maximally 5 to 10 %, enters the plasma unchanged.
The 90 to 95 % of the total PPT ingested, plus any mammalian glucuronides excreted through the bile, pass to the colon where they are metabolised by the gut microflora. Transformations may be extensive, and include the removal of sugars, removal of phenolic hydroxyl groups, fission of aromatic rings, and metabolism to carbon dioxide, possibly via oxaloacetate [88]. A substantial range of microbial metabolites has been identified, including phenols and aromatic/phenolic acids/lactones possessing 0, 1 or 2 phenolic hydroxyl groups and up to five carbons in the side chain [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111]. Eubacterium is of particular interest since this species not only metabolises dietary (poly)phenols [99], [100], [105], [106], [112], [113], [114], [115], [116], but also produces butyrate [117], a preferred energy source for colonic epithelial cells thought to play an important role in maintaining colon health in humans. The yield of phenolic/aromatic acids is variable (up to × 10) between individuals, but can be substantial (up to 50 %) relative to the intake of PPT substrates [95], [103], [104], [108], [109], [110].
There is evidence from cell culture studies that some of the aromatic/phenolic acids, e. g., benzoic, salicylic, p-coumaric and ferulic acids, are transported actively by the monocarboxylate transporter MCT1 [118], [119], [120], [121], [122]. A comparatively small percentage of these microbial metabolites may eventually appear unchanged in plasma or urine but the majority is subject to mammalian conjugation as described for intact PPT.
Table [2] summarises in a semi-quantitative manner so far as current knowledge allows the fate of a ”typical” daily consumption of some 450 to 600 mg of PPT (as aglycones) previously defined in Table [1].
Aglycones (mg) | |
Estimated mean daily consumption (from Table [1]) | 450 - 600 |
∼ 5 - 10 % of intake absorbed in duodenum and excreted in urine. Of this 5 - 10 % unchanged plant (poly)phenols, and 90 - 95 % mammalian conjugates | 22 - 60 < 6 20 - 55 |
∼ 90-95 % fermented in colon (unabsorbed PPT+ enteric and entero-hepatic cycling of glucuronides, etc.) Poorly-defined and very variable portion (5 to 50 %?) absorbed depending on individual’s flora and substrates. Mainly mammalian conjugates of microbial metabolites | 400 - 570 20 - 285 |
Plasma Pseudo-Pharmacokinetics
Since for the majority of dietary PPT, neither the conjugates consumed, nor their free aglycones, are detectable in plasma, it is rarely possible to perform true pharmacokinetic analyses. Most so-called pharmacokinetic data that have been published relate to the concentrations of aglycones released after hydrolysis of mammalian conjugates in plasma or urine with commercial β-glucuronidase and/or sulphatase, and the data so obtained are better referred to as pseudo-pharmacokinetics. Published data are summarised in Table [3]. Although the maximum concentration achieved transiently varies to some extent with PPT subclass and matrix in which consumed, it is unlikely that plasma metabolite concentrations will routinely exceed 10 μM in total, and approximately 1 μM for total aglycones. The reported T max values range from 1 to 2.5 hours for substances absorbed in the duodenum [85], [86], [87], [123], [124], [125], [126], [127], [128], [129], [130], up to 5 to 12 hours when microbial metabolism is a prerequisite [87], [104], [131]. Elimination half-lives are very variable, ranging from as low as 1 hour [132], [133] to values in excess of 20 hours [85], [6], [87]. The very low values may be artefacts of observation periods being less than the true half-life, whereas the very high values may be exaggerated because of a biphasic elimination reflecting significant entero-hepatic circulation of glucuronides. When studied explicitly, repeat dosing has failed to provide evidence of accumulation in plasma suggesting that, in general, significant elimination occurs in a time period shorter than the interval between repeat doses [123].
Table [4] summarises the concentrations of a range of endogenous (i. e., non-dietary) simple phenols, including α-tocopherol, and ascorbate in plasma from healthy individuals. The total simple phenol and ascorbate concentration is between 159 and 380 μM. The maximum additional concentration that is likely to be achieved from dietary sources, 3 to 22 μM, is marginal by comparison adding only between 0.3 and 5 % if it is assumed, quite reasonably, that the ”typical” mean intake is taken over three equal meals. Many people consume a much smaller quantity of dietary PPT and even those consuming double the average amount (450 to 600 mg aglycones) adopted in this paper will only achieve a transient 5 to10 % increase in total plasma antioxidant content.
Many investigators have attempted to demonstrate increases in plasma antioxidant capability following the consumption of foods, beverages or supplements rich in PPT. Table [5] summarises the outcomes of 34 such studies [127], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157], [158], [159]. The test substances included a range of fruit and vegetable products, including juices, alcoholic beverages, tea, and chocolate. In view of the calculations presented in Tables [3] and 4, it is perhaps not surprising that increases in plasma antioxidant capacity were often undetectable, and at best, small and transient. Moreover, in four studies that produced increases in plasma antioxidant capability it could be attributed, at least in part, to increased plasma ascorbate [149], [156], [158].
In view of these observations, it is instructive also to consider the redox potentials of PPT-derived mammalian metabolites that are known to reach plasma, and to compare these with the corresponding values for the endogenous plasma antioxidants. The polyphenols with the lowest redox potentials are flavonoids with vicinal hydroxyl groups in the B-ring, and conjugation extending to the A-ring, e. g., quercetin aglycone (330 mV at pH 7) [160]. If the conjugation does not extend beyond the B-ring, then the redox potential is significantly higher even for (-)-epigallocatechin gallate (480 mV at pH 7) [161] with three vicinal hydroxyl groups. The value rises again when there are only two vicinal hydroxyl groups {e. g., (+)-catechin 570 mV [162] or caffeic acid 540 mV [162]}, a single para hydroxyl group (e. g., hesperidin 720 mV [162]) or isolated (meta) hydroxyl groups (e. g., resorcinol 810 mV [163]). These comparisons are extended to the endogenous (non-dietary) plasma antioxidants in Table [6]. Fig. [1] illustrates the marked effects of mammalian and microbial metabolism on the redox potential of PPT aglycones that are frequently examined in in vitro systems designed to demonstrate their potent antioxidant properties. When the aglycones of such powerful antioxidants are given intravenously to humans [164] or intraperitoneally to animals [165], [166], thus circumventing the protection offered by the gastric mucosa and Phase II conjugations, redox cycling causes serious and possibly fatal liver and kidney damage. One may conclude that it is better to avoid high plasma concentrations of the more potent PPT antioxidants (such as unconjugated quercetin), and that it might be ill-advised grossly to supplement normal diets with capsules and concentrates of such potent antioxidants.
Table [6] indicates that the diet-derived PPT metabolites are able thermodynamically to scavenge some or all of the damaging radicals should they come into contact. However, these metabolites are so hydrophilic {e. g., quercetin 3-glucuronide (K = 0.008) [167], [168] compared with quercetin (K = 66) [167], [168] and α-tocopherol (K = 550) [169]} that it is unlikely they will encounter lipid-derived radicals. However, any phenoxyl radicals generated will have to be removed either by transfer of the unpaired electron to an endogenous scavenger such as α-tocopherol, ascorbate, glutathione or serum albumin, or by dismutation or disproportionation although these latter mechanisms seem somewhat unlikely in vivo because of the relatively low phenoxyl radical concentrations. The implied demand for α-tocopherol and ascorbate is particularly interesting, since two of the supplementation studies (Table [5]) produced reductions in plasma ascorbate and α-tocopherol [150], and the major sources of dietary PPT identified from the NEODIET database (coffee and black tea) supply neither. Moreover, it is known that for approximately 14 % of the over-65 population subgroup in the UK the mean plasma ascorbate value is below 11 μM [170], indicating biochemical depletion [171], suggesting that for heavy consumers of black tea or coffee within this population subgroup the transient concentration of PPT metabolites may approach or even exceed plasma ascorbate.
From the data assembled, it is difficult to envisage how diet-derived PPT metabolites can make a major contribution to radical scavenging in plasma compared with the contribution to be expected from the endogenous antioxidants in healthy individuals replete in ascorbate. It follows that if diets rich in fruits and vegetables are advantageous, at least in part, by virtue of their content of PPT then mechanisms other than radical scavenging are implicated.
PPT Subclass | C max (nM) unchangeda | C max (nM) mammalian conjugates | % urine excretion |
Anthocyanins | 10 - 150 | traces | N.D. - 0.1b |
Flavanols, low fat Flavanols, high fat | 40 - 140 150 - 220 | 1000 - 2000 up to 6200 | 0.5 - 4.0 25 - 30 |
Flavonol glycosides Flavonol aglycones | Minute traces Minute traces | N.D.b 350 - 1100 | 0.5 - 2.5 |
Flavanone glycosides | Minute traces | 120 - 1500 | 4 - 10 |
Isoflavone glycosides Isoflavone aglycones | Minute traces 10 - 150 | 900 - 4000 500 - 6500 | 20 - 55 |
Cinnamates & chlorogenic acids | up to 120 | up to 500 | 1 - 2 |
Phenolic gut flora metabolites | 20 - 60 | Up to 50 | |
Hypothetical total if all consumed in one meal | 250 - 780 | 2890 - 21660 | |
a C max = maximum concentration achieved transiently in plasma. | |||
b N.D. = not detected. |
Plasma concentration, healthy individuals |
|
Homogentisic acid p-Hydroxyphenyl lactate p-Hydroxyphenyl pyruvate Tyrosine | 0.014 - 0.070a
40 - 90b 14 - 60b 60 - 130b,c |
Ascorbate α-Tocopherol | 40 - 70d,e
5 - 30f |
Total endogenous phenols & antioxidants | 159 - 380 |
Hypothetical total diet-derived phenols Averaged over three meals gives a transient increase of between 0.3 and 5 %. Many people consume much less | 3.1 - 22.4g
≈ 1 - 7.5g |
a Ref. [201], b Ref. [202], c Ref. [203], d Ref. [204], e Ref. [205], f Ref. [206], g From Table [3] |
34 studies, (poly)phenol-rich diet compared with control |
- 13 studies (3 high & 3 very high doses) showed no change in plasma antioxidant status ex vivo |
- 21 studies (8 low & 7 moderate doses) showed small and transient increases in plasma antioxidant status ex vivo |
- 1 showed reduction in plasma Vitamin E |
- 1 showed reduction in plasma ascorbate and glutathione |
a Refs: [127], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157], [158], [159]. |
Mammalian metabolite hydroxylation pattern | Maximal transient concentration (μM) | Redox potential (mV) at pH 7 |
1,2,3-vic
1,2-vic Single para or isolated meta hydroxy groups Blocked/inactive | 0.14a
0.8a 10a ? | 400 - 600d,e,f
500 - 650d,g,h, 700 - 1050d,e,g,i,j,k Inactive |
Damaging radicals | Redox potential (mV) at pH 7 | |
Hydroxyl radical Superoxide radical anion Alkoxyl radical Alkyl-peroxyl radical PUFA (bis-allylic) radical | 2310 h
1800 h 1600 l 1000 ± 60h,l,m, 600 h |
|
Endogenous phenols and antioxidants in plasma | Typical plasma concentration (μm) | Redox potential (mV) at pH 7 |
Endogenous p-phenols α-Tocopherol Ascorbate (depleted) Glutathione | 114, 280a
5 - 30 50 - 70b (≤ 11)c | ≈ 700d,e,g,i,j,k
≈ 500d,h ≈ 280e,h - 276n |
a From Table [3], b From Table [4], c Ref. [170], d Ref. [161], e Ref. [163], f Ref. [207], g Ref. [162], h Ref. [208], i Ref. [209], j Ref. [210], k Ref. [211], l Ref. [212], m Ref. [213], n Ref. [214] |
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
Fig. 1 Illustration of the effects of mammalian metabolism and microbial metabolism on the redox potential of (poly)phenols found in plasma compared with their precursors in the diet and the aglycones commonly used in in vitro studies.
Protective Mechanisms other than Radical Scavenging
Although classically, mammalian conjugates of drugs are viewed as biologically significantly less active than the parent drug, this is not inevitably the case when PPT are considered. Some quercetin conjugates are able to inhibit lipoxygenase and xanthine oxidase. Quercetin 3-glucuronide, one of the three major human conjugates of dietary quercetin glycosides, has been shown in vitro to protect the vascular endothelium [172], [173] and suppresses peroxynitrite-induced consumption of lipophilic antioxidants in human LDL [174]. Another human metabolite, quercetin 4′-glucuronide, inhibits xanthine oxidase in vitro at a concentration in plasma that on normal diets can realistically be approached (K i = 0.25 μM) [175]. As these observations are more widely appreciated, and mammalian metabolites become more readily available, it is quite possible that other biologically interesting properties will be identified for mammalian conjugates of PPT.
Effects occurring in the gastro-intestinal tract prior to absorption also deserve greater consideration. For example, there is a growing body of evidence suggesting that diets rich in PPT may influence the absorption and metabolism of glucose, resulting in a lower glycaemic index [176] than would otherwise be expected. Red wine [177], coffee [178] and apple juice [179] have all been shown in controlled volunteer studies to slow glucose absorption and reduce the post-prandial surge in plasma glucose, an event known to be an independent risk factor for CHD [180]. Studies in which volunteers consumed normal portions of PPT-rich foods [178] have also produced reductions in the post-prandial concentrations of plasma insulin and glucose-dependent insulinotropic polypeptide and elevation in the concentration of glucagon-like polypeptide-1. A prospective study of 17,000 people suggested that the mean relative risk of developing Type II diabetes was only 0.5 (0.35 - 0.72) in those individuals habitually consuming six or more cups of coffee per day compared with those consuming two or less (p = 0.0002) [181], and a polyphenol-enriched diet has been reported to reduce the incidence and severity of nephropathy in Type II diabetics [182].
The reduced glycaemic index has been attributed to PPT-mediated inhibition of α-amylase [183], [184], maltase [185] or α-glucosidase (sucrase) [184], [186], but this mechanism would not operate with preformed glucose as observed in our studies [178], [179]. In studies using bolus doses of glucose, the observation is more conveniently explained by an effect on the active glucose transporter (SGLT1) in the duodenum. Phloridzin, a dihydrochalcone glucoside characteristic of apples and apple products [53], but now known to be more widely distributed [187], competes for the active site both in vitro and in vivo when given intraperitoneally [188], [189], [190], [191]. Other dietary PPT [(-)-epigallocatechin gallate, (-)-epigallocatechin and 5-caffeoylquinic acid] have been shown in vitro to dissipate the sodium gradient essential to the operation of SGLT1 [192], [193], and several quercetin glucosides have been shown to interact with it and thus to have the potential to interfere in glucose transport [194], [195], [196], [197], [198], [199], [200]. While these effects on glucose absorption and the associated hormones are modest, they have been achieved in volunteers consuming sensible quantities of common dietary components (as distinct from effects seen only in vitro with high levels of PPT aglycones never seen in the diet). Such effects repeated daily, or even several times daily for say 30 years, might in part explain the reduced incidence of chronic disease, especially Type II diabetes and the metabolic syndrome, in later life associated with diets rich in fruits and vegetables.
#Conclusions
Evidence has been presented to indicate that very little of the dietary PPT consumed reaches human plasma, and that this transient fraction contains only weak antioxidants able to make little contribution to the total antioxidant activity of the plasma. This suggests that radical scavenging by PPT is unlikely to be the mechanism by which diets rich in fruits and vegetables protect against chronic diseases. Instead, it is proposed that modulation of glucose absorption in the duodenum prior to the absorption of PPT, with protection by PPT metabolites through mechanisms other than radical scavenging, might over a lifetime offer modest protection against chronic diseases, especially Type II diabetes and the metabolic syndrome.
#References
- 1 Shahidi F, Naczk M. Food Phenolics: Sources; Chemistry; Effects; Applications. Lancaster, Pennsylvania; Technomic Publishing Inc. 1995: pp 1-321
- 2 Higdon J V, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. CRC Crit Rev Food Sci Nutr. 2003; 43 89-143
- 3 Sesso H D, Gaziano J M, Liu S, Buring J E. Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr. 2003; 77 1400-8
- 4 Stewart J R, Artime M C, O'Brian C A. Resveratrol: a candidate nutritional substance for prostate cancer prevention. J Nutr. 2003; 133 S2440-3
- 5 Kris-Etherton P M, Keen C L. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002; 13 41-9
- 6 Arts I C, Jacobs D R, Gross M, Harnack L J, Folsom A R. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women’s Health Study (United States). Cancer Causes Control. 2002; 13 373-82
- 7 Reed J. Cranberry flavonoids, atherosclerosis and cardiovascular health. CRC Crit Rev Food Sci Nutr. 2002; 42 301-16
- 8 Sampson L, Rimm E, Hollman P C, de Vries J H, Katan M B. Flavonol and flavone intakes in US health professionals. J Am Diet Assoc. 2002; 102 1414-20
- 9 Youdim K A, Spencer J P, Schroeter H, Rice-Evans C. Dietary flavonoids as potential neuroprotectants. Biol Chem. 2002; 383 503-19
- 10 Dillard C J, German J B. Phytochemicals: nutraceuticals and human health. J Sci Food Agric. 2000; 80 1744-56
- 11 Riemersma R A, Rice-Evans C A, Tyrrell R M, Clifford M N, Lean M EJ. Tea flavonoids and cardiovascular health. Quart J Med. 2001; 94 277-82
- 12 Parr A J, Bolwell G P. Phenols in the plant and in man. The potential for possible nutritional enhancement of the diet by modifying phenolic content or composition. J Sci Food Agric. 2000; 80 985-1012
- 13 Department of Health. Nutritional Aspects of the Development of Cancer. London; Her Majesty's Stationery Office 1998: pp 1-274
- 14 Ribereau-Gayon P. Plant phenolics. New York; Hafner Publishing Company 1972
- 15 Clifford M N. The health effects of tea and tea components. Appendix 1. A nomenclature for phenols with special reference to tea. CRC Crit Rev Food Sci Nutr. 2001; 41 393-7
- 16 Lindsay D G, Clifford M N. Special issue devoted to critical reviews produced within the EU Concerted Action ”Nutritional Enhancement of Plant-based Food in European Trade” (NEODIET). J Sci Food Agric. 2000; 80 793-1137
- 17 Clifford M N. Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. J Sci Food Agric. 1999; 79 362-72
- 18 Clifford M N. Chlorogenic acids and other cinnamates - nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric. 2000; 80 1033-42
- 19 Clifford M N. Miscellaneous phenols in foods and beverages - nature, occurrence and dietary burden. J Sci Food Agric. 2000; 80 1126-37
- 20 Soler-Rivas C, Espin J C, Wichers H J. Oleuropein and related compounds. J Sci Food Agric. 2000; 80 1013-23
- 21 Tomás-Barberán F A, Clifford M N. Dietary hydroxybenzoic acid derivatives - nature, occurrence and dietary burden. J Sci Food Agric. 2000; 80 1024-32
- 22 Hertog M GL, Hollman P CH, Katan M B. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits consumed in The Netherlands. J Agr Food Chem. 1992; 40 2379-83
- 23 Haslam E. Practical Polyphenolics. From structure to molecular recognition and physiological action. Cambridge; Cambridge University Press 1998: pp 1-438
- 24 Santos-Buelga C, Scalbert A. Proanthocyanidins and tannin-like compounds - nature, occurrence, dietary intake and effects on nutrition and health. J Sci Food Agric. 2000; 80 1094-1117
- 25 Clifford M N, Scalbert A. Ellagitannins - nature, occurrence and dietary burden. J Sci Food Agric. 2000; 80 1118-25
- 26 Cassidy A, Hanley B, Lamuela-Raventós R M. Isoflavones, lignans and stilbenes - origins, metabolism and potential importance to human health. J Sci Food Agric. 2000; 80 1044-62
- 27 Setchell K DR, Lawson A M, Borriello S P, Harkness R, Gordon H, Morgan D ML, Kirk D N, Adlercreutz H, Anderson L C. Lignan formation in man - microbial involvement and possible roles in relation to cancer. Lancet. 1981; ii 4-7
- 28 Diplock A T. Defence against reactive oxygen species. Free Radic Res. 1999; 29 4637
- 29 Kroon P A, Clifford M N, Crozier A, Day A J, Donovan J L, Manach C, Williamson G. COMMENTARY: How should we assess the effects of exposure to dietary polyphenols in vitro . Am J Clin Nutr. 2004; 80 15-21
- 30 Cameira-dos-Santos P -J, Brillouet J -M, Cheynier V, Moutounet M. Detection and partial characterisation of new anthocyanin-derived pigments in wine. J Sci Food Agric. 1996; 70 204-8
- 31 Fulcrand H, Cameira-dos-Santos P -J, Sarni-Manchado P, Cheynier V, Favre-Bonvin J. Structure of new anthocyanin-derived wine pigments. J Chem Soc Perkin Trans. 1996; 1 735-9
- 32 Bakker J, Bridle P, Honda P, Kuwano H, Saito N, Terahara N, Timberlake C F. Identification of an anthocyanin occurring in some red wines. Phytochemistry. 1997; 44 1375-82
- 33 Bakker J, Timberlake C F. Isolation, identification and characterization of new color-stable anthocyanins occurring in some red wines. J Agr Food Chem. 1997; 45 35-43
- 34 Davis A L, Lewis J R, Cai Y, Powell C, Davies A P, Wilkins J PG, Pudney P, Clifford M N. A polyphenolic pigment from black tea. Phytochemistry. 1997; 46 1397-402
- 35 Fulcrand H, Benabdeljalil C, Rigaud J, Cheynier V, Moutounet M. A new class of wine pigments yielded by reaction between pyruvic acid and the grape anthocyanins. Phytochemistry. 1998; 47 1401-7
-
36 Davies A P, Goodsall C, Cai Y, Davis A L, Lewis J R, Wilkins J, Wan X, Clifford M N, Powell C, Thiru A, Safford R, Nursten H E. Black tea dimeric and oligomeric pigments - structures and formation. In: Gross GG, Hemingway RW and Yoshida T, editors
Plant Polyphenols 2. Chemistry, Biology, Pharmacology, Ecology . Indian bend, Oregon, USA; Kluwer Academic 1999: pp 697-724 - 37 Vivar-Quintana A M, Santos-Buelga C, Francia-Aricha E, Rivas-Gonzalo J C. Formation of anthocyanin-derived pigments in experimental red wines. Food Science and Technology International. 1999; 5 347-52
- 38 Tanaka T, Betsumiya Y, Mine C, Kouno I. Theanaphthoquinone, a novel pigment oxidatively derived from theaflavin during tea fermentation. Chem Commun 2000: 1365-6
- 39 Mateus N, Silva A M, Santos-Buelga C, Rivas-Gonzalo J C, de F V. Identification of anthocyanin-flavanol pigments in red wines by NMR and mass spectrometry. J Agr Food Chem. 2002; 50 2110-6
- 40 Mateus N, de Pascual-Teresa S, Rivas-Gonzalo J C, Santos-Buelga C, de Freitas V. Structural diversity of anthocyanin-derived pigments in port wines. Food Chem. 2002; 76 335-42
- 41 Sang S, Tian W, Meng X, Stark R E, Rosen R T, Yang C S, Ho C -T. Theadibenztropolone A, a new type pigment from enzymatic oxidation of (-)-epicatechin and (-)-epigallocatechin gallate and characterized from black tea using LC/MS/MS. Tetrahedron Lett. 2002; 43 7129-33
- 42 Kühnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet. 1976; 24 117-91
- 43 Knekt P, Jarvinen R, Reunanen A, Maatela J, Lunetta M, di Mauro M, Crimi S, Mughini L. Flavonoid intake and coronary mortality in Finland: a cohort study. No important differences in glycaemic responses to common fruits in type 2 diabetic patients. Brit Med J. 1995; 12 674-8
- 44 Kimira M, Arai Y, Shimoi K, Watanabe S. Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol. 1998; 8 168-5
- 45 Linseisen J, Radtke J, Wolfram G. Flavonoid intake of adults in a Bavarian subgroup of the National Food Consumption survey. Z Ernährungswiss. 1997; 36 403-12
- 46 Radtke J, Linseisen J, Wolfram G. Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey. Z Ernährungswiss. 1998; 37 190-7
- 47 Hirvonen T, Pietinen P, Virtanen M, Ovaskainen M L, Hakkinen S, Albanes D, Virtamo J. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology. 2001; 12 62-7
- 48 Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control. 2001; 12 789-96
- 49 Gosnay S L, Bishop J A, New S A, Catterick J, Clifford M N. Estimation of the mean intakes of fourteen classes of dietary phenolics in a population of young British women aged 20 - 30 years. Proc Nutr Soc. 2002; 61 125A
- 50 Woods E, Clifford M N, Gibbs M, Hampton S, Arendt J, Morgan L. Estimation of mean intakes of 14 classes of dietary phenols in a population of male shift workers. Proc Nutr Soc. 2003; 62 60A
- 51 Hertog M GL, Sweetman P M, Fehily A M, Elwood P C, Kromhout D. Antioxidant flavonols and ischaemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr. 1997; 65 1489-94
- 52 Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr. 2000; 130 2243-50
- 53 Tomás-Barberán F A, Clifford M N. Flavanones, chalcones and dihydrochalcones - nature, occurrence and dietary burden. J Sci Food Agric. 2000; 80 1073-80
- 54 Price K R, Bacon J R, Rhodes M JC. Effect of storage and domestic processing on the content and composition of flavonol glucosides in onion (Allium cepa). J Agr Food Chem. 1997; 45 938-42
- 55 Ewald C, Fjelkner-Modig S, Johanssen K, Sjöholma I, Åkesson B. Effect of processing on major flavonoids in processed onions, green beans, and peas. Food Chem. 1999; 64 231-5
- 56 Chuda Y, Suzuki M, Nagata T, Tsushida T. Contents and cooking loss of three quinic acid derivatives from Garland (Chrysanthemum coronarium L.) J Agr Food Chem. 1998; 46 1437-9
- 57 Price K R, Casuscelli F, Colquhoun I J, Rhodes M JC. Composition and content of flavonol glycosides in broccoli floreets (Brassica oleracea) and their fate during cooking. J Sci Food Agric. 1998; 77 468-72
- 58 Ioku K, Aoyama Y, Tokuno A, Terao J, Nakatani N, Takei Y. Various cooking methods and the flavonoid content in onion. J Nutr Sci Vitaminol (Tokyo). 2001; 47 78-83
- 59 Brenes M, Garcia A, Dobarganes M C, Velasco J, Romero C. Influence of thermal treatments simulating cooking processes on the polyphenol content in virgin olive oil. J Agr Food Chem. 2002; 50 5962-7
- 60 Vallejo F, Tom F A, Garc C. Phenolic compound contents in edible parts of broccoli inflorescences after domestic cooking. J Sci Food Agric. 2003; 83 1511-6
-
61 Bond T A, Lewis J R, Davis A, Davies A P. Analysis and purification of catechins and their transformation products. In: Santos-Buelga C, Williamson G, editors
Methods in Polyphenol Analysis . Cambridge; Royal Society of Chemistry 2003: pp 229-66 - 62 Garcia-Closas R, Gonzalez C A, Agudo A, Riboli E. Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control. 1999; 10 71-5
- 63 Justesen U, Knuthsen P. Composition of flavonoids in fresh herbs and calculation of flavonoid intake by use of herbs in traditional Danish dishes. Food Chem. 2001; 73 245-50
- 64 Justesen U, Knuthsen P, Andersen N L, Leth T. Estimation of daily intake distribution of flavonols and flavanones in Denmark. Scand J Nutr. 2000; 44 158-60
- 65 Keli S O, Hertog M G, Feskens E J, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med. 1996; 156 637-42
- 66 Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E, Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epid. 1997; 146 223-30
- 67 Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. Brit Med J. 1996; 312 478-81
- 68 Knekt P, Isotupa S, Rissanen H, Heliovaara M, Jarvinen R, Hakkinen S, Aromaa A, Reunanen A. Quercetin intake and the incidence of cerebrovascular disease. Eur J Clin Nutr. 2000; 54 415-7
- 69 Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo J C. Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J Agric Food Chem. 2000; 48 5331-7
- 70 Arts I CW, van de Putte B, Hollman P CH. Catechin contents of foods commonly consumed in the Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agr Food Chem 2000: 1746-51
- 71 Arts I CW, Hollman P CH, Feskens E JM, de Mesquita B B, Kromhout D. Catechin intake is inversely associated with coronary heart disease mortality; Results from the Zutphen Elderly Study. Circulation. 2000; 101 4
- 72 Stewart A J, Bozonnet S, Mullen W, Jenkins G I, Lean M E, Crozier A. Occurrence of flavonols in tomatoes and tomato-based products. J Agr Food Chem. 2000; 48 2663-9
- 73 Crozier A, Burns J, Aziz A A, Stewart A J, Rabiasz H S, Jenkins G, Edwards C A, Lean M EJ. Antioxidant flavonols from fruits, vegetables and beverages: measurement and bioavailability. Biol Res. 2000; 33 79-88
- 74 Howard L R, Pandjaitan N, Morelock T, Gil M I. Antioxidant capacity and phenolic content of spinach as affected by genetics and growing season. J Agr Food Chem. 2002; 50 5891-6
- 75 Cacace J E, Mazza G. Extraction of anthocyanins and other phenolics from blackcurrants with sulfured water. J Agr Food Chem. 2002; 50 5939-46
- 76 Porteous L. Nutritional and dietary risk factors for osteoporosis: An investigation of association between diet and indices of bone health in young British women aged 25 - 30 years. B.Sc. Thesis. University of Surrey 2001
- 77 Bennett G. Food choices, dietary patterns and circulation adaptation in shift workers: an investigation into the possible impact on coronary heart disease risk. B.Sc. Thesis. University of Surrey 2001
- 78 Paul N. Do eating patterns and post-prandial hormonal and metabolic markers vary significantly according to shift type and circadian status in swing shift workers in the offshore oil industry. B.Sc. Thesis. University of Surrey 2001
- 79 Balentine D A, Wiseman S A, Bouwens C M. The chemistry of tea flavonoids. CRC Crit Rev Food Sci Nutr. 1997; 37 693-704
-
80 Clifford M N. Tea. In: Ranken MD, Kill RC and Baker CJG, editors
Food Industries Manual . 24th edition London; Blackie 1997: pp 379-95 - 81 Harbowy M E, Balentine D A. Tea Chemistry. CRC Crit Rev Plant Sci. 1997; 16 415-80
- 82 Olthof M R, Hollman P C, Buijsman M N, van Amelsvoort J M, Katan M B. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr. 2003; 133 1806-14
- 83 Nardini M, Cirillo E, Natella F, Scaccini C. Absorption of phenolic acids in humans after coffee consumption. J Agr Food Chem. 2002; 50 5735-41
- 84 Lee M -J, Wang Z -Y, Li H, Chen L, Sun Y, Gobbo S, Balentine D A, Yang C S. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev. 1995; 4 393-9
- 85 Hollman P C, Katan M B. Health effects and bioavailability of dietary flavonols. Free Radic Res. 1999; 31 Suppl S75-80
- 86 Olthof M R, Hollman P C, Vree T B, Katan M B. Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. J Nutr. 2000; 130 1200-3
- 87 Hollman P CH, van Trijp J M, Buysman M N, van der Gaag M S, Mengelers M J, de Vries J HM, Katan M B. Relative bioavailability of the antioxidant quercetin from various foods in man. FEBS Lett. 1997; 418 152-6
- 88 Walle T, Walle U K, Halushka P V. Carbon dioxide is the major metabolite of quercetin in humans. J Nutr. 2001; 131 2648-52
- 89 Krishnamurty H G, Cheng K J, Jones G A, Simpson F J, Watkin J E. Identification of products produced by the anaerobic degradation of rutin and related flavonoids by Butyrivibrio sp. C3. Can J Microbiol. 1970; 16 759-67
- 90 Scheline R R. The metabolism of (+)-catechin to hydroxyphenylvaleric acids by the intestinal microflora. Biochim Biophys Acta. 1970; 222 228-30
- 91 Scheline R R. Mammalian Metabolism of Plant Xenobiotics. London; Academic Press 1978: pp 1-502
-
92 Griffiths L A. Mammalian metabolism of flavonoids. In: Harborne JB, Mabry TJ, editors
The Flavonoids: Advances in Research . London; Chapman and Hall 1982: pp 681-718 - 93 Groenewoud G, Hundt H KL. The microbial metabolism of (+)-catechins to two novel diarylpropan-2-ol metabolites in vitro . Xenobiotica. 1984; 14 711-7
- 94 Bokkenheuser V D, Shackleton C H, Winter J. Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem J. 1987; 248 953-6
- 95 Sawai Y, Kohsaka K, Nishiyama Y, Ando K. Serum concentrations of rutoside metabolites after oral administration of a rutoside formulation to humans. Arzneimittel-Forsch. 1987; 37 729-32
- 96 Bokkenheuser V D, Winter J. Hydrolysis of flavonoids by human intestinal bacteria. Progress in Clinical & Biological Research. 1988; 280 143-5
- 97 Winter J, Moore L H, Dowell V R, Bokkenheuser V D. C-ring cleavage of flavonoids by human intestinal bacteria. Appl Environ Microbiol. 1989; 55 1203-8
- 98 Coldham N G, King L J, Macpherson D D, Sauer M J. Biotransformation of genistein in the rat: elucidation of metabolite structure by product ion mass fragmentology. J Steroid Biochem Mol Biol. 1999; 70 169-84
- 99 Schneider H, Schwiertz A, Collins M D, Blaut M. Anaerobic transformation of quercetin-3-glucoside by bacteria from the human intestinal tract. Arch Microbiol. 1999; 171 81-091
- 100 Simmering R, Kleessen B, Blaut M. Quantification of the flavonoid-degrading bacterium Eubacterium ramulus in human fecal samples with a species-specific oligonucleotide hybridization probe. Appl Environ Microbiol. 1999; 65 3705-9
- 101 Deprez S, Brezillon C, Rabot S, Philippe C, Mila I, Lapierre C, Scalbert A. Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J Nutr. 2000; 130 2733-8
- 102 Justesen U, Arrigoni E, Larsen B R, Amado R. Degradation of flavonoid glycosides and aglycones during in vitro fermentation with human faecal flora. Lebensm Wiss Technol. 2000; 33 424-30
- 103 Clifford M N, Copeland E L, Bloxsidge J P, Mitchell L A. Hippuric acid is a major excretion product associated with black tea consumption. Xenobiotica. 2000; 30 317-26
- 104 Li C, Lee M -J, Sheng S, Meng X, Prabhu S, Winnik B, Huang B, Chung J Y, Yan S, Ho C -T, Yang C S. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol. 2000; 13 177-84
- 105 Schneider H, Blaut M. Anaerobic degradation of flavonoids by Eubacterium ramulus . Arch Microbiol. 2000; 173 71-5
- 106 Schneider H, Simmering R, Hartmann L, Blaut M. Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J Appl Microbiol. 2000; 89 1027-37
- 107 Jenkins D I, Wolever T M, Taylor R H. Glycaemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981; 34 362-6
- 108 Couteau D, McCartney A L, Gibson G R, Williamson G, Faulds C B. Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J Appl Microbiol. 2001; 90 873-881
- 109 Olthof M R. Bioavailability of flavonoids and cinnamic acids and their effect on plasma homocysteine in humans. PhD Thesis. Wageningen University 2001: pp 136
- 110 Olthof M R, Hollman P CH, Katan M B. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr. 2001; 131 66-71
- 111 Aura A M, O'Leary K A, Williamson G, Ojala M, Bailey M, Puupponen-Pimia R, Nuutila A M, Oksman-Caldentey K M, Poutanen K. Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro . J Agr Food Chem. 2002; 50 1725-30
- 112 Schoefer L, Mohan R, Braune A, Birringer M, Blaut M. Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett. 2002; 208 197-202
- 113 Braune A, Gutschow M, Engst W, Blaut M. Degradation of quercetin and luteolin by Eubacterium ramulus . Appl Environ Microbiol. 2001; 67 5558-67
- 114 Wang L Q, Meselhy M R, Li Y, Nakamura N, Min B S, Qin G W, Hattori M. The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium. Chem Pharm Bull. 2001; 49 1640-3
- 115 Hur H, Rafii F. Biotransformation of the isoflavonoids biochanin A, formononetin, and glycitein by Eubacterium limosum . FEMS Microbiol Lett. 2000; 192 21-5
- 116 Wang L Q, Meselhy M R, Li Y, Qin G W, Hattori M. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem Pharm Bull. 2000; 48 1606-10
- 117 Barcenilla A, Pryde S E, Martin J C, Duncan S H, Stewart C S, Henderson C, Flint H J. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol. 2000; 66 1654-61
- 118 Takanaga H, Tamai I, Tsuji A. pH-dependent and carrier-mediated transport of salicylic acid across Caco-2 cells. J Pharm Pharmacol. 1994; 46 567-70
- 119 Tsuji A, Takanaga H, Tamai I, Terasaki T. Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm Res. 1994; 11 30-7
- 120 Tamai I, Takanaga H, Maeda H, Yabuuchi H, Sai Y, Suzuki Y, Tsuji A. Intestinal brush-border membrane transport of monocarboxylic acids mediated by proton-coupled transport and anion antiport mechanisms. J Pharm Pharmacol. 1997; 49 108-12
- 121 Konishi Y, Shimizu M. Transepithelial transport of ferulic acid by monocarboxylic acid transporter in Caco-2 cell monolayers. Biosci Biotechnol Biochem. 2003; 67 856-62
- 122 Konishi Y, Kobayashi S, Shimizu M. Transepithelial transport of p-coumaric acid and gallic acid in Caco-2 cell monolayers. Biosci Biotechnol Biochem. 2003; 67 2317-24
- 123 Baba S, Osakabe N, Yasuda A, Natsume M, Takizawa T, Nakamura T, Terao J. Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radic Res. 2000; 33 635-41
- 124 Bell J RC, Donovan J L, Wong R, Waterhouse A L, German J B, Walzem R L, Kasim-Karakas S E. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am J Clin Nutr. 2000; 71 103-8
- 125 Hollman P CH, van der Gaag M S, Mengelers M JB, van Trijp J MP, de Vries J HM, Katan M B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med. 1996; 21 703-7
- 126 Holt R R, Lazarus S A, Sullards M C, Zhu Q Y, Schramm D D, Hammerstone J F, Fraga C G, Schmitz H H, Keen C L. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr. 2002; 76 798-804
- 127 Kimura M, Umegaki K, Kasuya Y, Sugisawa A, Higuchi M. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr. 2002; 56 1186-93
- 128 McAnlis G T, McEneny J, Pearce J, Young I S. Absorption and antioxidant effects of quercetin from onions, in man. Eur J Clin Nutr. 1999; 53 92-6
-
129 van het Hof K, Wiseman S A, de Boer H, Weststrate N LJ, Tijburg L. Bioavailability and antioxidant activity of tea polyphenols in humans. In: Amadó R, Andersson H, Bardócz S and Serra F, editors
COST 916 Bioactive plant cell wall components in mutrition and health. Polyphenols in food . Luxembourg; EC 1998: 115 - 130 Wang J F, Schramm D D, Holt R R, Ensunsa J L, Fraga C G, Schmitz H H, Keen C L. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr. 2000; 130 2115S-9
- 131 Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Remesy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr. 2003; 57 235-42
- 132 Yang C S, Lee M J, Chen L. Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Cancer Epidemiology, Biomarkers & Prevention. 1999; 8 83-9
- 133 Meng X, Lee M J, Li C, Sheng S, Zhu N, Sang S, Ho C T, Yang C S. Formation and identification of 4′-O-methyl-(-)-epigallocatechin in humans. Drug Metab Dispos. 2001; 29 789-93
- 134 Caccetta R A, Croft K D, Beilin L J, Puddey I B. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr. 2000; 71 67-74
- 135 Carbonneau M A, Leger C L, Monnier L, Bonnet C, Michel F, Fouret G, Dedieu F, Descomps B. Supplementation with wine phenolic compounds increases the antioxidant capacity of plasma and vitamin E of low-density lipoprotein without changing the lipoprotein Cu(2+)-oxidizability: possible explanation by phenolic location. Eur J Clin Nutr. 1997; 51 682-90
- 136 Conquer J A, Maiani G, Azzini E, Raguzzini A, Holub B J. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr. 1998; 128 593-7
- 137 Eccleston C, Baoru Y, Tahvonen R, Kallio H, Rimbach G H, Minihane A M. Effects of an antioxidant-rich juice (sea buckthorn) on risk factors for coronary heart disease in humans. J Nutr Biochem. 2002; 13 346-54
- 138 Ghiselli A, Natella F, Guidi A, Montanari L, Fantozzi P, Scaccini C. Beer increases plasma antioxidant capacity in humans. J Nutr Biochem. 2000; 11 76-80
- 139 Hodgson J M, Puddey I B, Croft K D, Burke V, Mori T A, Caccetta R A, Beilin L J. Acute effects of ingestion of black and green tea on lipoprotein oxidation. Am J Clin Nutr. 2000; 71 1103-7
- 140 Hodgson J M, Puddey I B, Croft K D, Mori T A, Rivera J, Beilin L J. Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure. Atherosclerosis. 1999; 145 167-72
- 141 Leenen R, Roodenburg A J, Tijburg L B, Wiseman S A. A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr. 2000; 54 87-92
- 142 Mathur S, Devaraj S, Grundy S M, Jialal I. Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J Nutr. 2002; 132 3663-7
- 143 Mazza G, Kay C D, Cottrell T, Holub B J. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agr Food Chem. 2002; 50 7731-7
- 144 Mitchell J H, Collins A R. Effects of a soy milk supplement on plasma cholesterol levels and oxidative DNA damage in men - a pilot study. Eur J Nutr. 1999; 38 143-8
- 145 Nakagawa K, Ninomiya M, Okubo T, Aoi N, Juneja L R, Kim M, Yamanaka K, Miyazawa T. Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans. J Agr Food Chem. 1999; 47 3967-73
- 146 Natella F, Belelli F, Gentili V, Ursini F, Scaccini C. Grape seed proanthocyanidins prevent plasma postprandial oxidative stress in humans. J Agr Food Chem. 2002; 50 7720-5
- 147 Nigdikar S V, Williams N R, Griffin B A, Howard A N. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo . Am J Clin Nutr. 1998; 68 258-65
- 148 O'Byrne D J, Devaraj S, Grundy S M, Jialal I. Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr. 2002; 76 1367-74
- 149 Pedersen C B, Kyle J, Jenkinson A M, Gardner P T, McPhail D B, Duthie G G. Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy female volunteers. Eur J Clin Nutr. 2000; 54 405-8
- 150 Princen H M, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg L B, Langius J A, Meinders A E, Pijl H. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol. 1998; 18 833-41
- 151 Rein D, Lotito S, Holt R R, Keen C L, Schmitz H H, Fraga C G. Epicatechin in human plasma: In vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr. 2000; 130 2109S-14
- 152 Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J Nutr. 1998; 128 1003-7
- 153 Simonetti P, Ciappellano S, Gardana C, Bramati L, Pietta P. Procyanidins from Vitis vinifera seeds: in vivo effects on oxidative stress. J Agr Food Chem. 2002; 50 6217-21
- 154 Stein J H, Keevil J G, Wiebe D A, Aeschlimann S, Folts J D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 1999; 100 1050-5
- 155 Tikkanen M J, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA. 1998; 95 3106-10
- 156 van den Berg R, van Vliet T, Broekmans W MR, Cnubben N HP, Vaes W HJ, Roza L, Haenen G RMM, Bast A, van den Berg H. A vegetable/fruit concentrate with high antioxidant capacity has no effect on biomarkers of antioxidant status in male smokers. J Nutr. 2001; 131 1714-22
- 157 Wan Y, Vinson J A, Etherton T D, Proch J, Lazarus S A, Kris-Etherton P M. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr. 2001; 74 596-602
- 158 Young J F, Nielsen S E, Haraldsdottir J, Daneshvar B, Lauridsen S T, Knuthsen P, Crozier A, Sandstrom B, Dragsted L O. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am J Clin Nutr. 1999; 69 87-94
- 159 Lotito S B, Frei B. Relevance of apple polyphenols as antioxidants in human plasma: contrasting in vitro and in vivo effects. Free Radic Biol Med. 2004; 36 201-11
- 160 Jovanovic S V, Steenken S, Hara Y, Simic M G. Reduction potentials of flavonoid and model phenoxyl radicals. Which ring in flavonoids is responsible for antioxidant activity?. J Chem Soc Perkin Trans. 1996; 2 2497-504
- 161 Jovanovic S V, Hara Y, Steenken S, Simic M G. Antioxidant potential of gallocatechins. A pulse radiolysis and laser photolysis study. J Am Chem Soc. 1995; 117 9881-8
- 162 Jovanovic S V, Steenken S, Tosic M, Marjanovic B, Simic M G. Flavonoids as antioxidants. J Am Chem Soc. 1994; 116 4846-51
- 163 Steenken S, Neta P. One-electron redox potentials of phenols. Hydroxy and amino-phenols and related compounds of biological interest. J Phys Chem 1982: 3661-7
- 164 Ferry D R, Smith A, Malkhandi J, Fyfe D W, deTakats P G, Anderson D, Baker J, Kerr D J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996; 2 659-68
- 165 Ayrton A D, Lewis D FV, Walker R, Ioannides C. Antimutagenicity of ellagic acid toward the food mutagen IQ: investigations into the possible mechanisms of action. Food Chem Toxicol. 1992; 30 289-95
- 166 Hirose Y, Tanaka T, Kawamori T, Ohnishi M, Makita H, Mori H, Satoh K, Hara A. Chemoprevention of urinary-bladder carcinogenesis by the natural phenolic compound protocatechuic acid in rats. Carcinogen. 1995; 16 2337-42
- 167 Shirai M, Moon J H, Tsushida T, Terao J. Inhibitory effect of a quercetin metabolite, quercetin 3-O-β-D-glucuronide, on lipid peroxidation in liposomal membranes. J Agr Food Chem. 2001; 49 5602-8
-
168 Terao J, Murota K, Moon J -H. Quercetin glucosides as dietary antioxidants in blood plasma: modulation of their function by metabolic conversion. In: Yoshikawa T, Toyokuni Y, Yamamoto Y and Naito Y, editors
Free radicals in chemistry, biology and medicine . London; OIAC International 2000: pp 462-75 - 169 Liao K, Yin M. Individual and combined antioxidant effects of seven phenolic agents in human erythrocyte membrane ghosts and phosphatidylcholine liposome systems: importance of the partition coefficient. J Agr Food Chem. 2000; 48 2266-70
- 170 Finch S, Doyle W, Lowe C, Bates C J, Prentice A, Smithers G, Clarke P C. National Diet and Nutrition Survey. People aged 65 years and over. London; The Stationery Office 1998
- 171 Sauberlich H E. Human requirements and needs. Vitamin C status: methods and findings. Ann NY Acad Sci. 1975; 258 438-50
- 172 Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon J H, Terao J, Tamaki T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun. 2002; 293 1458-65
- 173 Nees S, Weiss D R, Reichenbach-Klinke E, Rampp F, Heilmeier B, Kanbach J, Esperester A. Protective effects of flavonoids contained in the red vine leaf on venular endothelium against the attack of activated blood components in vitro . Arzneimittel-Forsch. 2003; 53 33-41
- 174 Terao J, Yamaguchi S, Shirai M, Miyoshi M, Moon J H, Oshima S, Inakuma T, Tsushida T, Kato Y. Protection by quercetin and quercetin 3-O-β-d-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein. Free Radic Res. 2001; 35 925-31
- 175 Day A J, Bao Y, Morgan M RA, Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med. 2000; 29 1234-43
- 176 Thompson L U, Yoon J H, Jenkins D J, Wolever T M, Jenkins A L. Relationship between polyphenol intake and blood glucose response of normal and diabetic individuals. Am J Clin Nutr. 1984; 39 745-51
- 177 Gin H, Rigalleau V, Caubet O, Masquelier J, Aubertin J. Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin-dependent diabetic patients and on starch digestibility in vitro . Metabolism. 1999; 48 1179-83
- 178 Johnston K L, Clifford M N, Morgan L M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr. 2003; 78 728-33
- 179 Johnston K L, Clifford M N, Morgan L M. Possible role for apple juice phenolic compounds in the acute modification of glucose tolerance and gastrointestinal hormone secretion in humans. J Sci Food Agric. 2002; 82 1800-5
- 180 Coutinho M, Gerstein H C, Wang Y, Yusef S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999; 22 233-40
- 181 van Dam R M, Feskens E J. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002; 360 1477-8
- 182 Facchini F S, Saylor K L. A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy. Diabetes. 2003; 52 1204-9
- 183 Hara Y, Honda M. The inhibition of a-amylase by tea polyphenols. Agric Biol Chem. 1990; 54 1939-45
- 184 Matsumoto N, Ishigaki F, Ishigaki A, Iwashina H, Hara Y. Reduction of blood-glucose levels by tea catechin. Biosci Biotechnol Biochem. 1993; 57 525-7
- 185 Matsui T, Ebuchi S, Kobayashi M, Fukui K, Sugita K, Terahara N, Matsumoto K. Anti-hyperglycemic effect of diacylated anthocyanin derived from Ipomoea batatas cultivar Ayamurasaki can be achieved through the α-glucosidase inhibitory action. J Agr Food Chem. 2002; 50 7244-8
- 186 Kawabata J, Mizuhata K, Sato E, Nishioka T, Aoyama Y, Kasai T. 6-hydroxyflavonoids as α-glucosidase inhibitors from marjoram (Origanum majorana) leaves. Biosci Biotechnol Biochem. 2003; 67 445-7
- 187 Hilt P, Schieber A, Yildirim C, Arnold G, Klaiber I, Conrad J, Beifuss U, Carle R. Detection of phloridzin in strawberries (Fragaria x ananassa Duch.) by HPLC-PDA-MS/MS and NMR spectroscopy. J Agr Food Chem. 2003; 51 2896-9
- 188 Nakazawa F. Influence of phloridzin on intestinal absorption. Tohoku J Exptl Med. 1922; 3 288-94
- 189 Alvarado F. Hypothesis for the interaction of phlorizin and phloretin with membrane carriers for sugars. Biochim Biophys Acta. 1967; 135 483-95
- 190 Alvarado F, Crane R K. Phlorizin as a competitive inhibitor of the active transport of sugars by hamster small intestine. Biochim Biophys Acta. 1962; 56 170-2
- 191 Crane R K. Intestinal absorption of sugars. Phys Rev. 1960; 40 789-825
- 192 Welsch C A, Lachance P A, Wasserman B P. Dietary phenolic compounds: Inhibition of Na+-dependent d-glucose uptake in rat intestinal brush border membrane vesicles. J Nutr. 1989; 119 1698-1704
- 193 Kobayashi Y, Suzuki M, Satsu H, Arai S, Hara Y, Suzuki K, Miyamoto Y, Shimizu M. Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J Agr Food Chem. 2000; 48 5618-23
- 194 Noteborn H PJM, Jansen E, Benito S, Mengelers M JB. Oral absorption and metabolism of quercetin and sugar-conjugated derivatives in specific transport systems. Cancer Lett. 1997; 114 175-7
- 195 Walgren R A, Walle U K, Walle T. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem Pharmacol. 1998; 55 1721-7
- 196 Gee J M, DuPont M S, Rhodes M JC, Johnson I T. Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radic Biol Med. 1998; 25 19-25
- 197 Walgren R A, Lin J T, Kinne R K, Walle T. Cellular uptake of dietary flavonoid quercetin 4′-β-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther. 2000; 294 837-43
- 198 Walgren R A, Karnaky K J Jr., Lindenmayer G E, Walle T. Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther. 2000; 294 830-6
- 199 Song J, Kwon O, Chen S, Daruwala R, Eck P, Park J B, Levine M. Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and glucose. J Biol Chem. 2002; 277 15 252-60
- 200 Wolffram S, Block M, Ader P. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J Nutr. 2002; 132 630-5
- 201 Deutsch J C, SanthoshKumar C R. Quantitation of homogentisic acid in normal human plasma. J Chromatogr B Biomed Appl. 1996; 667 147-51
- 202 Deutsch J C. Determination of p-hydroxyphenylpyruvate, p-hydroxyphenyllactate and tyrosine in normal human plasma by gas chromatography-mass spectrometry isotope-dilution assay. J Chromatogr B. 1997; 690 1-6
- 203 Heinecke J W. Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Toxicology. 2002; 177 11-22
- 204 Gregory J R, Collins D L, Davies P SW, Hughes J M, Clarke P C. National Diet and Nutrition Survey. Children aged one and a half years to four and a half years. London; HMSO 1995
- 205 Gregory J, Lowe S, Bates C J, Prentice A, Jackson L V, Smithers G, Wenlock R, Farron M. National Diet and Nutrition Survey. Young people aged 4 to 18 years. London; The Stationery Office 2000
- 206 Halliwell B, Gutteridge J M. Free Radicals in Biology and Medicine. 3th edition Oxford; Oxford University Press 1999
- 207 Jovanovic S V, Hara Y, Steenken S, Simic M G. Antioxidant potential of theaflavins. a pulse radiolysis study. J Am Chem Soc. 1997; 119 5337-43
- 208 Buettner G R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys. 1993; 300 535-43
- 209 Jovanovic S V, Steenken S, Boone C W, Simic M G. H-atom transfer is a preferred antioxidant mechanism of curcumin. J Am Chem Soc. 1999; 121 9677-81
- 210 Steenken S, Neta P. Electron transfer rates and equilibria between substituted phenoxide ions and phenoxyl radicals. J Phys Chem. 1979; 83 1134-7
- 211 Jovanovic S V, Tosic M, Simic M G. Use of Hammett correlation and σ+ for calculation of one-electron redox potentials of antioxidants. J Phys Chem. 1991; 95 10 824-7
- 212 Koppenol W H. Oxyradical reactions: from bond-dissociation energies to reduction potentials. FEBS Lett. 1990; 264 165-7
- 213 Jovanovic S V, Jankovic I, Josimovic L. Electron transfer reactions of alkyl peroxy radicals. J Am Chem Soc. 1992; 114 9018-21
- 214 Jones D P, Carlson J L, Mody V C, Cai J, Lynn M J, Sternberg P. Redox state of glutathione in human plasma. Free Radic Biol Med. 2000; 28 625-35
M. N. Clifford
Centre for Nutrition & Food Safety
School of Biomedical & Molecular Sciences
University of Surrey
Guildford
Surrey GU2 7XH
UK
Fax: +44-1483-300374
Email: M.Clifford@Surrey.ac.uk
References
- 1 Shahidi F, Naczk M. Food Phenolics: Sources; Chemistry; Effects; Applications. Lancaster, Pennsylvania; Technomic Publishing Inc. 1995: pp 1-321
- 2 Higdon J V, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. CRC Crit Rev Food Sci Nutr. 2003; 43 89-143
- 3 Sesso H D, Gaziano J M, Liu S, Buring J E. Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr. 2003; 77 1400-8
- 4 Stewart J R, Artime M C, O'Brian C A. Resveratrol: a candidate nutritional substance for prostate cancer prevention. J Nutr. 2003; 133 S2440-3
- 5 Kris-Etherton P M, Keen C L. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002; 13 41-9
- 6 Arts I C, Jacobs D R, Gross M, Harnack L J, Folsom A R. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women’s Health Study (United States). Cancer Causes Control. 2002; 13 373-82
- 7 Reed J. Cranberry flavonoids, atherosclerosis and cardiovascular health. CRC Crit Rev Food Sci Nutr. 2002; 42 301-16
- 8 Sampson L, Rimm E, Hollman P C, de Vries J H, Katan M B. Flavonol and flavone intakes in US health professionals. J Am Diet Assoc. 2002; 102 1414-20
- 9 Youdim K A, Spencer J P, Schroeter H, Rice-Evans C. Dietary flavonoids as potential neuroprotectants. Biol Chem. 2002; 383 503-19
- 10 Dillard C J, German J B. Phytochemicals: nutraceuticals and human health. J Sci Food Agric. 2000; 80 1744-56
- 11 Riemersma R A, Rice-Evans C A, Tyrrell R M, Clifford M N, Lean M EJ. Tea flavonoids and cardiovascular health. Quart J Med. 2001; 94 277-82
- 12 Parr A J, Bolwell G P. Phenols in the plant and in man. The potential for possible nutritional enhancement of the diet by modifying phenolic content or composition. J Sci Food Agric. 2000; 80 985-1012
- 13 Department of Health. Nutritional Aspects of the Development of Cancer. London; Her Majesty's Stationery Office 1998: pp 1-274
- 14 Ribereau-Gayon P. Plant phenolics. New York; Hafner Publishing Company 1972
- 15 Clifford M N. The health effects of tea and tea components. Appendix 1. A nomenclature for phenols with special reference to tea. CRC Crit Rev Food Sci Nutr. 2001; 41 393-7
- 16 Lindsay D G, Clifford M N. Special issue devoted to critical reviews produced within the EU Concerted Action ”Nutritional Enhancement of Plant-based Food in European Trade” (NEODIET). J Sci Food Agric. 2000; 80 793-1137
- 17 Clifford M N. Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. J Sci Food Agric. 1999; 79 362-72
- 18 Clifford M N. Chlorogenic acids and other cinnamates - nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric. 2000; 80 1033-42
- 19 Clifford M N. Miscellaneous phenols in foods and beverages - nature, occurrence and dietary burden. J Sci Food Agric. 2000; 80 1126-37
- 20 Soler-Rivas C, Espin J C, Wichers H J. Oleuropein and related compounds. J Sci Food Agric. 2000; 80 1013-23
- 21 Tomás-Barberán F A, Clifford M N. Dietary hydroxybenzoic acid derivatives - nature, occurrence and dietary burden. J Sci Food Agric. 2000; 80 1024-32
- 22 Hertog M GL, Hollman P CH, Katan M B. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits consumed in The Netherlands. J Agr Food Chem. 1992; 40 2379-83
- 23 Haslam E. Practical Polyphenolics. From structure to molecular recognition and physiological action. Cambridge; Cambridge University Press 1998: pp 1-438
- 24 Santos-Buelga C, Scalbert A. Proanthocyanidins and tannin-like compounds - nature, occurrence, dietary intake and effects on nutrition and health. J Sci Food Agric. 2000; 80 1094-1117
- 25 Clifford M N, Scalbert A. Ellagitannins - nature, occurrence and dietary burden. J Sci Food Agric. 2000; 80 1118-25
- 26 Cassidy A, Hanley B, Lamuela-Raventós R M. Isoflavones, lignans and stilbenes - origins, metabolism and potential importance to human health. J Sci Food Agric. 2000; 80 1044-62
- 27 Setchell K DR, Lawson A M, Borriello S P, Harkness R, Gordon H, Morgan D ML, Kirk D N, Adlercreutz H, Anderson L C. Lignan formation in man - microbial involvement and possible roles in relation to cancer. Lancet. 1981; ii 4-7
- 28 Diplock A T. Defence against reactive oxygen species. Free Radic Res. 1999; 29 4637
- 29 Kroon P A, Clifford M N, Crozier A, Day A J, Donovan J L, Manach C, Williamson G. COMMENTARY: How should we assess the effects of exposure to dietary polyphenols in vitro . Am J Clin Nutr. 2004; 80 15-21
- 30 Cameira-dos-Santos P -J, Brillouet J -M, Cheynier V, Moutounet M. Detection and partial characterisation of new anthocyanin-derived pigments in wine. J Sci Food Agric. 1996; 70 204-8
- 31 Fulcrand H, Cameira-dos-Santos P -J, Sarni-Manchado P, Cheynier V, Favre-Bonvin J. Structure of new anthocyanin-derived wine pigments. J Chem Soc Perkin Trans. 1996; 1 735-9
- 32 Bakker J, Bridle P, Honda P, Kuwano H, Saito N, Terahara N, Timberlake C F. Identification of an anthocyanin occurring in some red wines. Phytochemistry. 1997; 44 1375-82
- 33 Bakker J, Timberlake C F. Isolation, identification and characterization of new color-stable anthocyanins occurring in some red wines. J Agr Food Chem. 1997; 45 35-43
- 34 Davis A L, Lewis J R, Cai Y, Powell C, Davies A P, Wilkins J PG, Pudney P, Clifford M N. A polyphenolic pigment from black tea. Phytochemistry. 1997; 46 1397-402
- 35 Fulcrand H, Benabdeljalil C, Rigaud J, Cheynier V, Moutounet M. A new class of wine pigments yielded by reaction between pyruvic acid and the grape anthocyanins. Phytochemistry. 1998; 47 1401-7
-
36 Davies A P, Goodsall C, Cai Y, Davis A L, Lewis J R, Wilkins J, Wan X, Clifford M N, Powell C, Thiru A, Safford R, Nursten H E. Black tea dimeric and oligomeric pigments - structures and formation. In: Gross GG, Hemingway RW and Yoshida T, editors
Plant Polyphenols 2. Chemistry, Biology, Pharmacology, Ecology . Indian bend, Oregon, USA; Kluwer Academic 1999: pp 697-724 - 37 Vivar-Quintana A M, Santos-Buelga C, Francia-Aricha E, Rivas-Gonzalo J C. Formation of anthocyanin-derived pigments in experimental red wines. Food Science and Technology International. 1999; 5 347-52
- 38 Tanaka T, Betsumiya Y, Mine C, Kouno I. Theanaphthoquinone, a novel pigment oxidatively derived from theaflavin during tea fermentation. Chem Commun 2000: 1365-6
- 39 Mateus N, Silva A M, Santos-Buelga C, Rivas-Gonzalo J C, de F V. Identification of anthocyanin-flavanol pigments in red wines by NMR and mass spectrometry. J Agr Food Chem. 2002; 50 2110-6
- 40 Mateus N, de Pascual-Teresa S, Rivas-Gonzalo J C, Santos-Buelga C, de Freitas V. Structural diversity of anthocyanin-derived pigments in port wines. Food Chem. 2002; 76 335-42
- 41 Sang S, Tian W, Meng X, Stark R E, Rosen R T, Yang C S, Ho C -T. Theadibenztropolone A, a new type pigment from enzymatic oxidation of (-)-epicatechin and (-)-epigallocatechin gallate and characterized from black tea using LC/MS/MS. Tetrahedron Lett. 2002; 43 7129-33
- 42 Kühnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet. 1976; 24 117-91
- 43 Knekt P, Jarvinen R, Reunanen A, Maatela J, Lunetta M, di Mauro M, Crimi S, Mughini L. Flavonoid intake and coronary mortality in Finland: a cohort study. No important differences in glycaemic responses to common fruits in type 2 diabetic patients. Brit Med J. 1995; 12 674-8
- 44 Kimira M, Arai Y, Shimoi K, Watanabe S. Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol. 1998; 8 168-5
- 45 Linseisen J, Radtke J, Wolfram G. Flavonoid intake of adults in a Bavarian subgroup of the National Food Consumption survey. Z Ernährungswiss. 1997; 36 403-12
- 46 Radtke J, Linseisen J, Wolfram G. Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey. Z Ernährungswiss. 1998; 37 190-7
- 47 Hirvonen T, Pietinen P, Virtanen M, Ovaskainen M L, Hakkinen S, Albanes D, Virtamo J. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology. 2001; 12 62-7
- 48 Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control. 2001; 12 789-96
- 49 Gosnay S L, Bishop J A, New S A, Catterick J, Clifford M N. Estimation of the mean intakes of fourteen classes of dietary phenolics in a population of young British women aged 20 - 30 years. Proc Nutr Soc. 2002; 61 125A
- 50 Woods E, Clifford M N, Gibbs M, Hampton S, Arendt J, Morgan L. Estimation of mean intakes of 14 classes of dietary phenols in a population of male shift workers. Proc Nutr Soc. 2003; 62 60A
- 51 Hertog M GL, Sweetman P M, Fehily A M, Elwood P C, Kromhout D. Antioxidant flavonols and ischaemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr. 1997; 65 1489-94
- 52 Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr. 2000; 130 2243-50
- 53 Tomás-Barberán F A, Clifford M N. Flavanones, chalcones and dihydrochalcones - nature, occurrence and dietary burden. J Sci Food Agric. 2000; 80 1073-80
- 54 Price K R, Bacon J R, Rhodes M JC. Effect of storage and domestic processing on the content and composition of flavonol glucosides in onion (Allium cepa). J Agr Food Chem. 1997; 45 938-42
- 55 Ewald C, Fjelkner-Modig S, Johanssen K, Sjöholma I, Åkesson B. Effect of processing on major flavonoids in processed onions, green beans, and peas. Food Chem. 1999; 64 231-5
- 56 Chuda Y, Suzuki M, Nagata T, Tsushida T. Contents and cooking loss of three quinic acid derivatives from Garland (Chrysanthemum coronarium L.) J Agr Food Chem. 1998; 46 1437-9
- 57 Price K R, Casuscelli F, Colquhoun I J, Rhodes M JC. Composition and content of flavonol glycosides in broccoli floreets (Brassica oleracea) and their fate during cooking. J Sci Food Agric. 1998; 77 468-72
- 58 Ioku K, Aoyama Y, Tokuno A, Terao J, Nakatani N, Takei Y. Various cooking methods and the flavonoid content in onion. J Nutr Sci Vitaminol (Tokyo). 2001; 47 78-83
- 59 Brenes M, Garcia A, Dobarganes M C, Velasco J, Romero C. Influence of thermal treatments simulating cooking processes on the polyphenol content in virgin olive oil. J Agr Food Chem. 2002; 50 5962-7
- 60 Vallejo F, Tom F A, Garc C. Phenolic compound contents in edible parts of broccoli inflorescences after domestic cooking. J Sci Food Agric. 2003; 83 1511-6
-
61 Bond T A, Lewis J R, Davis A, Davies A P. Analysis and purification of catechins and their transformation products. In: Santos-Buelga C, Williamson G, editors
Methods in Polyphenol Analysis . Cambridge; Royal Society of Chemistry 2003: pp 229-66 - 62 Garcia-Closas R, Gonzalez C A, Agudo A, Riboli E. Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control. 1999; 10 71-5
- 63 Justesen U, Knuthsen P. Composition of flavonoids in fresh herbs and calculation of flavonoid intake by use of herbs in traditional Danish dishes. Food Chem. 2001; 73 245-50
- 64 Justesen U, Knuthsen P, Andersen N L, Leth T. Estimation of daily intake distribution of flavonols and flavanones in Denmark. Scand J Nutr. 2000; 44 158-60
- 65 Keli S O, Hertog M G, Feskens E J, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med. 1996; 156 637-42
- 66 Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E, Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epid. 1997; 146 223-30
- 67 Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. Brit Med J. 1996; 312 478-81
- 68 Knekt P, Isotupa S, Rissanen H, Heliovaara M, Jarvinen R, Hakkinen S, Aromaa A, Reunanen A. Quercetin intake and the incidence of cerebrovascular disease. Eur J Clin Nutr. 2000; 54 415-7
- 69 Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo J C. Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J Agric Food Chem. 2000; 48 5331-7
- 70 Arts I CW, van de Putte B, Hollman P CH. Catechin contents of foods commonly consumed in the Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agr Food Chem 2000: 1746-51
- 71 Arts I CW, Hollman P CH, Feskens E JM, de Mesquita B B, Kromhout D. Catechin intake is inversely associated with coronary heart disease mortality; Results from the Zutphen Elderly Study. Circulation. 2000; 101 4
- 72 Stewart A J, Bozonnet S, Mullen W, Jenkins G I, Lean M E, Crozier A. Occurrence of flavonols in tomatoes and tomato-based products. J Agr Food Chem. 2000; 48 2663-9
- 73 Crozier A, Burns J, Aziz A A, Stewart A J, Rabiasz H S, Jenkins G, Edwards C A, Lean M EJ. Antioxidant flavonols from fruits, vegetables and beverages: measurement and bioavailability. Biol Res. 2000; 33 79-88
- 74 Howard L R, Pandjaitan N, Morelock T, Gil M I. Antioxidant capacity and phenolic content of spinach as affected by genetics and growing season. J Agr Food Chem. 2002; 50 5891-6
- 75 Cacace J E, Mazza G. Extraction of anthocyanins and other phenolics from blackcurrants with sulfured water. J Agr Food Chem. 2002; 50 5939-46
- 76 Porteous L. Nutritional and dietary risk factors for osteoporosis: An investigation of association between diet and indices of bone health in young British women aged 25 - 30 years. B.Sc. Thesis. University of Surrey 2001
- 77 Bennett G. Food choices, dietary patterns and circulation adaptation in shift workers: an investigation into the possible impact on coronary heart disease risk. B.Sc. Thesis. University of Surrey 2001
- 78 Paul N. Do eating patterns and post-prandial hormonal and metabolic markers vary significantly according to shift type and circadian status in swing shift workers in the offshore oil industry. B.Sc. Thesis. University of Surrey 2001
- 79 Balentine D A, Wiseman S A, Bouwens C M. The chemistry of tea flavonoids. CRC Crit Rev Food Sci Nutr. 1997; 37 693-704
-
80 Clifford M N. Tea. In: Ranken MD, Kill RC and Baker CJG, editors
Food Industries Manual . 24th edition London; Blackie 1997: pp 379-95 - 81 Harbowy M E, Balentine D A. Tea Chemistry. CRC Crit Rev Plant Sci. 1997; 16 415-80
- 82 Olthof M R, Hollman P C, Buijsman M N, van Amelsvoort J M, Katan M B. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr. 2003; 133 1806-14
- 83 Nardini M, Cirillo E, Natella F, Scaccini C. Absorption of phenolic acids in humans after coffee consumption. J Agr Food Chem. 2002; 50 5735-41
- 84 Lee M -J, Wang Z -Y, Li H, Chen L, Sun Y, Gobbo S, Balentine D A, Yang C S. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev. 1995; 4 393-9
- 85 Hollman P C, Katan M B. Health effects and bioavailability of dietary flavonols. Free Radic Res. 1999; 31 Suppl S75-80
- 86 Olthof M R, Hollman P C, Vree T B, Katan M B. Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. J Nutr. 2000; 130 1200-3
- 87 Hollman P CH, van Trijp J M, Buysman M N, van der Gaag M S, Mengelers M J, de Vries J HM, Katan M B. Relative bioavailability of the antioxidant quercetin from various foods in man. FEBS Lett. 1997; 418 152-6
- 88 Walle T, Walle U K, Halushka P V. Carbon dioxide is the major metabolite of quercetin in humans. J Nutr. 2001; 131 2648-52
- 89 Krishnamurty H G, Cheng K J, Jones G A, Simpson F J, Watkin J E. Identification of products produced by the anaerobic degradation of rutin and related flavonoids by Butyrivibrio sp. C3. Can J Microbiol. 1970; 16 759-67
- 90 Scheline R R. The metabolism of (+)-catechin to hydroxyphenylvaleric acids by the intestinal microflora. Biochim Biophys Acta. 1970; 222 228-30
- 91 Scheline R R. Mammalian Metabolism of Plant Xenobiotics. London; Academic Press 1978: pp 1-502
-
92 Griffiths L A. Mammalian metabolism of flavonoids. In: Harborne JB, Mabry TJ, editors
The Flavonoids: Advances in Research . London; Chapman and Hall 1982: pp 681-718 - 93 Groenewoud G, Hundt H KL. The microbial metabolism of (+)-catechins to two novel diarylpropan-2-ol metabolites in vitro . Xenobiotica. 1984; 14 711-7
- 94 Bokkenheuser V D, Shackleton C H, Winter J. Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem J. 1987; 248 953-6
- 95 Sawai Y, Kohsaka K, Nishiyama Y, Ando K. Serum concentrations of rutoside metabolites after oral administration of a rutoside formulation to humans. Arzneimittel-Forsch. 1987; 37 729-32
- 96 Bokkenheuser V D, Winter J. Hydrolysis of flavonoids by human intestinal bacteria. Progress in Clinical & Biological Research. 1988; 280 143-5
- 97 Winter J, Moore L H, Dowell V R, Bokkenheuser V D. C-ring cleavage of flavonoids by human intestinal bacteria. Appl Environ Microbiol. 1989; 55 1203-8
- 98 Coldham N G, King L J, Macpherson D D, Sauer M J. Biotransformation of genistein in the rat: elucidation of metabolite structure by product ion mass fragmentology. J Steroid Biochem Mol Biol. 1999; 70 169-84
- 99 Schneider H, Schwiertz A, Collins M D, Blaut M. Anaerobic transformation of quercetin-3-glucoside by bacteria from the human intestinal tract. Arch Microbiol. 1999; 171 81-091
- 100 Simmering R, Kleessen B, Blaut M. Quantification of the flavonoid-degrading bacterium Eubacterium ramulus in human fecal samples with a species-specific oligonucleotide hybridization probe. Appl Environ Microbiol. 1999; 65 3705-9
- 101 Deprez S, Brezillon C, Rabot S, Philippe C, Mila I, Lapierre C, Scalbert A. Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J Nutr. 2000; 130 2733-8
- 102 Justesen U, Arrigoni E, Larsen B R, Amado R. Degradation of flavonoid glycosides and aglycones during in vitro fermentation with human faecal flora. Lebensm Wiss Technol. 2000; 33 424-30
- 103 Clifford M N, Copeland E L, Bloxsidge J P, Mitchell L A. Hippuric acid is a major excretion product associated with black tea consumption. Xenobiotica. 2000; 30 317-26
- 104 Li C, Lee M -J, Sheng S, Meng X, Prabhu S, Winnik B, Huang B, Chung J Y, Yan S, Ho C -T, Yang C S. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol. 2000; 13 177-84
- 105 Schneider H, Blaut M. Anaerobic degradation of flavonoids by Eubacterium ramulus . Arch Microbiol. 2000; 173 71-5
- 106 Schneider H, Simmering R, Hartmann L, Blaut M. Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J Appl Microbiol. 2000; 89 1027-37
- 107 Jenkins D I, Wolever T M, Taylor R H. Glycaemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981; 34 362-6
- 108 Couteau D, McCartney A L, Gibson G R, Williamson G, Faulds C B. Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J Appl Microbiol. 2001; 90 873-881
- 109 Olthof M R. Bioavailability of flavonoids and cinnamic acids and their effect on plasma homocysteine in humans. PhD Thesis. Wageningen University 2001: pp 136
- 110 Olthof M R, Hollman P CH, Katan M B. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr. 2001; 131 66-71
- 111 Aura A M, O'Leary K A, Williamson G, Ojala M, Bailey M, Puupponen-Pimia R, Nuutila A M, Oksman-Caldentey K M, Poutanen K. Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro . J Agr Food Chem. 2002; 50 1725-30
- 112 Schoefer L, Mohan R, Braune A, Birringer M, Blaut M. Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett. 2002; 208 197-202
- 113 Braune A, Gutschow M, Engst W, Blaut M. Degradation of quercetin and luteolin by Eubacterium ramulus . Appl Environ Microbiol. 2001; 67 5558-67
- 114 Wang L Q, Meselhy M R, Li Y, Nakamura N, Min B S, Qin G W, Hattori M. The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium. Chem Pharm Bull. 2001; 49 1640-3
- 115 Hur H, Rafii F. Biotransformation of the isoflavonoids biochanin A, formononetin, and glycitein by Eubacterium limosum . FEMS Microbiol Lett. 2000; 192 21-5
- 116 Wang L Q, Meselhy M R, Li Y, Qin G W, Hattori M. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem Pharm Bull. 2000; 48 1606-10
- 117 Barcenilla A, Pryde S E, Martin J C, Duncan S H, Stewart C S, Henderson C, Flint H J. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol. 2000; 66 1654-61
- 118 Takanaga H, Tamai I, Tsuji A. pH-dependent and carrier-mediated transport of salicylic acid across Caco-2 cells. J Pharm Pharmacol. 1994; 46 567-70
- 119 Tsuji A, Takanaga H, Tamai I, Terasaki T. Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm Res. 1994; 11 30-7
- 120 Tamai I, Takanaga H, Maeda H, Yabuuchi H, Sai Y, Suzuki Y, Tsuji A. Intestinal brush-border membrane transport of monocarboxylic acids mediated by proton-coupled transport and anion antiport mechanisms. J Pharm Pharmacol. 1997; 49 108-12
- 121 Konishi Y, Shimizu M. Transepithelial transport of ferulic acid by monocarboxylic acid transporter in Caco-2 cell monolayers. Biosci Biotechnol Biochem. 2003; 67 856-62
- 122 Konishi Y, Kobayashi S, Shimizu M. Transepithelial transport of p-coumaric acid and gallic acid in Caco-2 cell monolayers. Biosci Biotechnol Biochem. 2003; 67 2317-24
- 123 Baba S, Osakabe N, Yasuda A, Natsume M, Takizawa T, Nakamura T, Terao J. Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radic Res. 2000; 33 635-41
- 124 Bell J RC, Donovan J L, Wong R, Waterhouse A L, German J B, Walzem R L, Kasim-Karakas S E. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am J Clin Nutr. 2000; 71 103-8
- 125 Hollman P CH, van der Gaag M S, Mengelers M JB, van Trijp J MP, de Vries J HM, Katan M B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med. 1996; 21 703-7
- 126 Holt R R, Lazarus S A, Sullards M C, Zhu Q Y, Schramm D D, Hammerstone J F, Fraga C G, Schmitz H H, Keen C L. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr. 2002; 76 798-804
- 127 Kimura M, Umegaki K, Kasuya Y, Sugisawa A, Higuchi M. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr. 2002; 56 1186-93
- 128 McAnlis G T, McEneny J, Pearce J, Young I S. Absorption and antioxidant effects of quercetin from onions, in man. Eur J Clin Nutr. 1999; 53 92-6
-
129 van het Hof K, Wiseman S A, de Boer H, Weststrate N LJ, Tijburg L. Bioavailability and antioxidant activity of tea polyphenols in humans. In: Amadó R, Andersson H, Bardócz S and Serra F, editors
COST 916 Bioactive plant cell wall components in mutrition and health. Polyphenols in food . Luxembourg; EC 1998: 115 - 130 Wang J F, Schramm D D, Holt R R, Ensunsa J L, Fraga C G, Schmitz H H, Keen C L. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr. 2000; 130 2115S-9
- 131 Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Remesy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr. 2003; 57 235-42
- 132 Yang C S, Lee M J, Chen L. Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Cancer Epidemiology, Biomarkers & Prevention. 1999; 8 83-9
- 133 Meng X, Lee M J, Li C, Sheng S, Zhu N, Sang S, Ho C T, Yang C S. Formation and identification of 4′-O-methyl-(-)-epigallocatechin in humans. Drug Metab Dispos. 2001; 29 789-93
- 134 Caccetta R A, Croft K D, Beilin L J, Puddey I B. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr. 2000; 71 67-74
- 135 Carbonneau M A, Leger C L, Monnier L, Bonnet C, Michel F, Fouret G, Dedieu F, Descomps B. Supplementation with wine phenolic compounds increases the antioxidant capacity of plasma and vitamin E of low-density lipoprotein without changing the lipoprotein Cu(2+)-oxidizability: possible explanation by phenolic location. Eur J Clin Nutr. 1997; 51 682-90
- 136 Conquer J A, Maiani G, Azzini E, Raguzzini A, Holub B J. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr. 1998; 128 593-7
- 137 Eccleston C, Baoru Y, Tahvonen R, Kallio H, Rimbach G H, Minihane A M. Effects of an antioxidant-rich juice (sea buckthorn) on risk factors for coronary heart disease in humans. J Nutr Biochem. 2002; 13 346-54
- 138 Ghiselli A, Natella F, Guidi A, Montanari L, Fantozzi P, Scaccini C. Beer increases plasma antioxidant capacity in humans. J Nutr Biochem. 2000; 11 76-80
- 139 Hodgson J M, Puddey I B, Croft K D, Burke V, Mori T A, Caccetta R A, Beilin L J. Acute effects of ingestion of black and green tea on lipoprotein oxidation. Am J Clin Nutr. 2000; 71 1103-7
- 140 Hodgson J M, Puddey I B, Croft K D, Mori T A, Rivera J, Beilin L J. Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure. Atherosclerosis. 1999; 145 167-72
- 141 Leenen R, Roodenburg A J, Tijburg L B, Wiseman S A. A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr. 2000; 54 87-92
- 142 Mathur S, Devaraj S, Grundy S M, Jialal I. Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J Nutr. 2002; 132 3663-7
- 143 Mazza G, Kay C D, Cottrell T, Holub B J. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agr Food Chem. 2002; 50 7731-7
- 144 Mitchell J H, Collins A R. Effects of a soy milk supplement on plasma cholesterol levels and oxidative DNA damage in men - a pilot study. Eur J Nutr. 1999; 38 143-8
- 145 Nakagawa K, Ninomiya M, Okubo T, Aoi N, Juneja L R, Kim M, Yamanaka K, Miyazawa T. Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans. J Agr Food Chem. 1999; 47 3967-73
- 146 Natella F, Belelli F, Gentili V, Ursini F, Scaccini C. Grape seed proanthocyanidins prevent plasma postprandial oxidative stress in humans. J Agr Food Chem. 2002; 50 7720-5
- 147 Nigdikar S V, Williams N R, Griffin B A, Howard A N. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo . Am J Clin Nutr. 1998; 68 258-65
- 148 O'Byrne D J, Devaraj S, Grundy S M, Jialal I. Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr. 2002; 76 1367-74
- 149 Pedersen C B, Kyle J, Jenkinson A M, Gardner P T, McPhail D B, Duthie G G. Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy female volunteers. Eur J Clin Nutr. 2000; 54 405-8
- 150 Princen H M, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg L B, Langius J A, Meinders A E, Pijl H. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol. 1998; 18 833-41
- 151 Rein D, Lotito S, Holt R R, Keen C L, Schmitz H H, Fraga C G. Epicatechin in human plasma: In vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr. 2000; 130 2109S-14
- 152 Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J Nutr. 1998; 128 1003-7
- 153 Simonetti P, Ciappellano S, Gardana C, Bramati L, Pietta P. Procyanidins from Vitis vinifera seeds: in vivo effects on oxidative stress. J Agr Food Chem. 2002; 50 6217-21
- 154 Stein J H, Keevil J G, Wiebe D A, Aeschlimann S, Folts J D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 1999; 100 1050-5
- 155 Tikkanen M J, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA. 1998; 95 3106-10
- 156 van den Berg R, van Vliet T, Broekmans W MR, Cnubben N HP, Vaes W HJ, Roza L, Haenen G RMM, Bast A, van den Berg H. A vegetable/fruit concentrate with high antioxidant capacity has no effect on biomarkers of antioxidant status in male smokers. J Nutr. 2001; 131 1714-22
- 157 Wan Y, Vinson J A, Etherton T D, Proch J, Lazarus S A, Kris-Etherton P M. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr. 2001; 74 596-602
- 158 Young J F, Nielsen S E, Haraldsdottir J, Daneshvar B, Lauridsen S T, Knuthsen P, Crozier A, Sandstrom B, Dragsted L O. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am J Clin Nutr. 1999; 69 87-94
- 159 Lotito S B, Frei B. Relevance of apple polyphenols as antioxidants in human plasma: contrasting in vitro and in vivo effects. Free Radic Biol Med. 2004; 36 201-11
- 160 Jovanovic S V, Steenken S, Hara Y, Simic M G. Reduction potentials of flavonoid and model phenoxyl radicals. Which ring in flavonoids is responsible for antioxidant activity?. J Chem Soc Perkin Trans. 1996; 2 2497-504
- 161 Jovanovic S V, Hara Y, Steenken S, Simic M G. Antioxidant potential of gallocatechins. A pulse radiolysis and laser photolysis study. J Am Chem Soc. 1995; 117 9881-8
- 162 Jovanovic S V, Steenken S, Tosic M, Marjanovic B, Simic M G. Flavonoids as antioxidants. J Am Chem Soc. 1994; 116 4846-51
- 163 Steenken S, Neta P. One-electron redox potentials of phenols. Hydroxy and amino-phenols and related compounds of biological interest. J Phys Chem 1982: 3661-7
- 164 Ferry D R, Smith A, Malkhandi J, Fyfe D W, deTakats P G, Anderson D, Baker J, Kerr D J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996; 2 659-68
- 165 Ayrton A D, Lewis D FV, Walker R, Ioannides C. Antimutagenicity of ellagic acid toward the food mutagen IQ: investigations into the possible mechanisms of action. Food Chem Toxicol. 1992; 30 289-95
- 166 Hirose Y, Tanaka T, Kawamori T, Ohnishi M, Makita H, Mori H, Satoh K, Hara A. Chemoprevention of urinary-bladder carcinogenesis by the natural phenolic compound protocatechuic acid in rats. Carcinogen. 1995; 16 2337-42
- 167 Shirai M, Moon J H, Tsushida T, Terao J. Inhibitory effect of a quercetin metabolite, quercetin 3-O-β-D-glucuronide, on lipid peroxidation in liposomal membranes. J Agr Food Chem. 2001; 49 5602-8
-
168 Terao J, Murota K, Moon J -H. Quercetin glucosides as dietary antioxidants in blood plasma: modulation of their function by metabolic conversion. In: Yoshikawa T, Toyokuni Y, Yamamoto Y and Naito Y, editors
Free radicals in chemistry, biology and medicine . London; OIAC International 2000: pp 462-75 - 169 Liao K, Yin M. Individual and combined antioxidant effects of seven phenolic agents in human erythrocyte membrane ghosts and phosphatidylcholine liposome systems: importance of the partition coefficient. J Agr Food Chem. 2000; 48 2266-70
- 170 Finch S, Doyle W, Lowe C, Bates C J, Prentice A, Smithers G, Clarke P C. National Diet and Nutrition Survey. People aged 65 years and over. London; The Stationery Office 1998
- 171 Sauberlich H E. Human requirements and needs. Vitamin C status: methods and findings. Ann NY Acad Sci. 1975; 258 438-50
- 172 Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon J H, Terao J, Tamaki T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun. 2002; 293 1458-65
- 173 Nees S, Weiss D R, Reichenbach-Klinke E, Rampp F, Heilmeier B, Kanbach J, Esperester A. Protective effects of flavonoids contained in the red vine leaf on venular endothelium against the attack of activated blood components in vitro . Arzneimittel-Forsch. 2003; 53 33-41
- 174 Terao J, Yamaguchi S, Shirai M, Miyoshi M, Moon J H, Oshima S, Inakuma T, Tsushida T, Kato Y. Protection by quercetin and quercetin 3-O-β-d-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein. Free Radic Res. 2001; 35 925-31
- 175 Day A J, Bao Y, Morgan M RA, Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med. 2000; 29 1234-43
- 176 Thompson L U, Yoon J H, Jenkins D J, Wolever T M, Jenkins A L. Relationship between polyphenol intake and blood glucose response of normal and diabetic individuals. Am J Clin Nutr. 1984; 39 745-51
- 177 Gin H, Rigalleau V, Caubet O, Masquelier J, Aubertin J. Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin-dependent diabetic patients and on starch digestibility in vitro . Metabolism. 1999; 48 1179-83
- 178 Johnston K L, Clifford M N, Morgan L M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr. 2003; 78 728-33
- 179 Johnston K L, Clifford M N, Morgan L M. Possible role for apple juice phenolic compounds in the acute modification of glucose tolerance and gastrointestinal hormone secretion in humans. J Sci Food Agric. 2002; 82 1800-5
- 180 Coutinho M, Gerstein H C, Wang Y, Yusef S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999; 22 233-40
- 181 van Dam R M, Feskens E J. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002; 360 1477-8
- 182 Facchini F S, Saylor K L. A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy. Diabetes. 2003; 52 1204-9
- 183 Hara Y, Honda M. The inhibition of a-amylase by tea polyphenols. Agric Biol Chem. 1990; 54 1939-45
- 184 Matsumoto N, Ishigaki F, Ishigaki A, Iwashina H, Hara Y. Reduction of blood-glucose levels by tea catechin. Biosci Biotechnol Biochem. 1993; 57 525-7
- 185 Matsui T, Ebuchi S, Kobayashi M, Fukui K, Sugita K, Terahara N, Matsumoto K. Anti-hyperglycemic effect of diacylated anthocyanin derived from Ipomoea batatas cultivar Ayamurasaki can be achieved through the α-glucosidase inhibitory action. J Agr Food Chem. 2002; 50 7244-8
- 186 Kawabata J, Mizuhata K, Sato E, Nishioka T, Aoyama Y, Kasai T. 6-hydroxyflavonoids as α-glucosidase inhibitors from marjoram (Origanum majorana) leaves. Biosci Biotechnol Biochem. 2003; 67 445-7
- 187 Hilt P, Schieber A, Yildirim C, Arnold G, Klaiber I, Conrad J, Beifuss U, Carle R. Detection of phloridzin in strawberries (Fragaria x ananassa Duch.) by HPLC-PDA-MS/MS and NMR spectroscopy. J Agr Food Chem. 2003; 51 2896-9
- 188 Nakazawa F. Influence of phloridzin on intestinal absorption. Tohoku J Exptl Med. 1922; 3 288-94
- 189 Alvarado F. Hypothesis for the interaction of phlorizin and phloretin with membrane carriers for sugars. Biochim Biophys Acta. 1967; 135 483-95
- 190 Alvarado F, Crane R K. Phlorizin as a competitive inhibitor of the active transport of sugars by hamster small intestine. Biochim Biophys Acta. 1962; 56 170-2
- 191 Crane R K. Intestinal absorption of sugars. Phys Rev. 1960; 40 789-825
- 192 Welsch C A, Lachance P A, Wasserman B P. Dietary phenolic compounds: Inhibition of Na+-dependent d-glucose uptake in rat intestinal brush border membrane vesicles. J Nutr. 1989; 119 1698-1704
- 193 Kobayashi Y, Suzuki M, Satsu H, Arai S, Hara Y, Suzuki K, Miyamoto Y, Shimizu M. Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J Agr Food Chem. 2000; 48 5618-23
- 194 Noteborn H PJM, Jansen E, Benito S, Mengelers M JB. Oral absorption and metabolism of quercetin and sugar-conjugated derivatives in specific transport systems. Cancer Lett. 1997; 114 175-7
- 195 Walgren R A, Walle U K, Walle T. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem Pharmacol. 1998; 55 1721-7
- 196 Gee J M, DuPont M S, Rhodes M JC, Johnson I T. Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radic Biol Med. 1998; 25 19-25
- 197 Walgren R A, Lin J T, Kinne R K, Walle T. Cellular uptake of dietary flavonoid quercetin 4′-β-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther. 2000; 294 837-43
- 198 Walgren R A, Karnaky K J Jr., Lindenmayer G E, Walle T. Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther. 2000; 294 830-6
- 199 Song J, Kwon O, Chen S, Daruwala R, Eck P, Park J B, Levine M. Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and glucose. J Biol Chem. 2002; 277 15 252-60
- 200 Wolffram S, Block M, Ader P. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J Nutr. 2002; 132 630-5
- 201 Deutsch J C, SanthoshKumar C R. Quantitation of homogentisic acid in normal human plasma. J Chromatogr B Biomed Appl. 1996; 667 147-51
- 202 Deutsch J C. Determination of p-hydroxyphenylpyruvate, p-hydroxyphenyllactate and tyrosine in normal human plasma by gas chromatography-mass spectrometry isotope-dilution assay. J Chromatogr B. 1997; 690 1-6
- 203 Heinecke J W. Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Toxicology. 2002; 177 11-22
- 204 Gregory J R, Collins D L, Davies P SW, Hughes J M, Clarke P C. National Diet and Nutrition Survey. Children aged one and a half years to four and a half years. London; HMSO 1995
- 205 Gregory J, Lowe S, Bates C J, Prentice A, Jackson L V, Smithers G, Wenlock R, Farron M. National Diet and Nutrition Survey. Young people aged 4 to 18 years. London; The Stationery Office 2000
- 206 Halliwell B, Gutteridge J M. Free Radicals in Biology and Medicine. 3th edition Oxford; Oxford University Press 1999
- 207 Jovanovic S V, Hara Y, Steenken S, Simic M G. Antioxidant potential of theaflavins. a pulse radiolysis study. J Am Chem Soc. 1997; 119 5337-43
- 208 Buettner G R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys. 1993; 300 535-43
- 209 Jovanovic S V, Steenken S, Boone C W, Simic M G. H-atom transfer is a preferred antioxidant mechanism of curcumin. J Am Chem Soc. 1999; 121 9677-81
- 210 Steenken S, Neta P. Electron transfer rates and equilibria between substituted phenoxide ions and phenoxyl radicals. J Phys Chem. 1979; 83 1134-7
- 211 Jovanovic S V, Tosic M, Simic M G. Use of Hammett correlation and σ+ for calculation of one-electron redox potentials of antioxidants. J Phys Chem. 1991; 95 10 824-7
- 212 Koppenol W H. Oxyradical reactions: from bond-dissociation energies to reduction potentials. FEBS Lett. 1990; 264 165-7
- 213 Jovanovic S V, Jankovic I, Josimovic L. Electron transfer reactions of alkyl peroxy radicals. J Am Chem Soc. 1992; 114 9018-21
- 214 Jones D P, Carlson J L, Mody V C, Cai J, Lynn M J, Sternberg P. Redox state of glutathione in human plasma. Free Radic Biol Med. 2000; 28 625-35
M. N. Clifford
Centre for Nutrition & Food Safety
School of Biomedical & Molecular Sciences
University of Surrey
Guildford
Surrey GU2 7XH
UK
Fax: +44-1483-300374
Email: M.Clifford@Surrey.ac.uk
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
Fig. 1 Illustration of the effects of mammalian metabolism and microbial metabolism on the redox potential of (poly)phenols found in plasma compared with their precursors in the diet and the aglycones commonly used in in vitro studies.